Viewing Study NCT01061151

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:38 PM
Ignite Modification Date: 2026-02-20 @ 6:41 PM
Study NCT ID: NCT01061151
Status: COMPLETED
Last Update Posted: 2022-02-11
First Post: 2010-02-01
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Evaluating Strategies to Reduce Mother-to-Child Transmission of HIV Infection in Resource-Limited Countries
Sponsor:
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Raw JSON

{'hasResults': True, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}, 'conditionBrowseModule': {'meshes': [{'id': 'D015658', 'term': 'HIV Infections'}, {'id': 'D001942', 'term': 'Breast Feeding'}], 'ancestors': [{'id': 'D000086982', 'term': 'Blood-Borne Infections'}, {'id': 'D003141', 'term': 'Communicable Diseases'}, {'id': 'D007239', 'term': 'Infections'}, {'id': 'D015229', 'term': 'Sexually Transmitted Diseases, Viral'}, {'id': 'D012749', 'term': 'Sexually Transmitted Diseases'}, {'id': 'D016180', 'term': 'Lentivirus Infections'}, {'id': 'D012192', 'term': 'Retroviridae Infections'}, {'id': 'D012327', 'term': 'RNA Virus Infections'}, {'id': 'D014777', 'term': 'Virus Diseases'}, {'id': 'D000091662', 'term': 'Genital Diseases'}, {'id': 'D000091642', 'term': 'Urogenital Diseases'}, {'id': 'D007153', 'term': 'Immunologic Deficiency Syndromes'}, {'id': 'D007154', 'term': 'Immune System Diseases'}, {'id': 'D005247', 'term': 'Feeding Behavior'}, {'id': 'D001519', 'term': 'Behavior'}]}, 'interventionBrowseModule': {'meshes': [{'id': 'D015215', 'term': 'Zidovudine'}, {'id': 'D019829', 'term': 'Nevirapine'}, {'id': 'D000069480', 'term': 'Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination'}, {'id': 'C109078', 'term': 'lamivudine, zidovudine drug combination'}, {'id': 'D061466', 'term': 'Lopinavir'}], 'ancestors': [{'id': 'D013936', 'term': 'Thymidine'}, {'id': 'D011741', 'term': 'Pyrimidine Nucleosides'}, {'id': 'D011743', 'term': 'Pyrimidines'}, {'id': 'D006573', 'term': 'Heterocyclic Compounds, 1-Ring'}, {'id': 'D006571', 'term': 'Heterocyclic Compounds'}, {'id': 'D015224', 'term': 'Dideoxynucleosides'}, {'id': 'D003853', 'term': 'Deoxyribonucleosides'}, {'id': 'D009705', 'term': 'Nucleosides'}, {'id': 'D009706', 'term': 'Nucleic Acids, Nucleotides, and Nucleosides'}, {'id': 'D011725', 'term': 'Pyridines'}, {'id': 'D000068698', 'term': 'Tenofovir'}, {'id': 'D063065', 'term': 'Organophosphonates'}, {'id': 'D009943', 'term': 'Organophosphorus Compounds'}, {'id': 'D009930', 'term': 'Organic Chemicals'}, {'id': 'D000068679', 'term': 'Emtricitabine'}, {'id': 'D003841', 'term': 'Deoxycytidine'}, {'id': 'D003562', 'term': 'Cytidine'}, {'id': 'D000225', 'term': 'Adenine'}, {'id': 'D011687', 'term': 'Purines'}, {'id': 'D006574', 'term': 'Heterocyclic Compounds, 2-Ring'}, {'id': 'D000072471', 'term': 'Heterocyclic Compounds, Fused-Ring'}, {'id': 'D004338', 'term': 'Drug Combinations'}, {'id': 'D004364', 'term': 'Pharmaceutical Preparations'}, {'id': 'D011744', 'term': 'Pyrimidinones'}]}}, 'resultsSection': {'moreInfoModule': {'pointOfContact': {'email': 'IMPAACT.ctgov@fstrf.org', 'phone': '(919) 405-1429', 'title': 'IMPAACT Clinicaltrials.gov Coordinator', 'organization': 'Family Health International (FHI 360)'}, 'certainAgreement': {'otherDetails': 'In accordance with the Clinical Trials Agreement between NIAID (DAIDS) and company collaborators, NIAID (DAIDS) provides companies with a copy of any abstract, press release, or manuscript prior to submission for publication with sufficient time for company review and comment. The publication/other disclosure can be delayed for up to 30 additional business days for manuscripts and five (5) business days for abstracts, to preserve U.S. or foreign patent or other intellectual property rights', 'restrictionType': 'OTHER', 'piSponsorEmployee': False, 'restrictiveAgreement': True}}, 'adverseEventsModule': {'timeFrame': 'From study entry (for mothers) or birth (for infants) until study completion on September 30, 2016, an average of 169 weeks for mothers and through 24 months or September 30, 2016 for infants, whichever came first.', 'description': 'Some women lost their infant before delivery. Expedited adverse event (AE) reporting followed Intensive Division of AIDS (DAIDS) Reporting Level, which included AEs resulting in death, congenital anomalies, fetal losses, significant disabilities requiring hospitalization and all grade 2 and higher hematology or chemistry events and grade 3 or 4 sign or symptoms. These events were graded using the DAIDS AE Grading Table, Version 1.0, 2009, available on the RSC website (http://rsc.tech-res.com).', 'eventGroups': [{'id': 'EG000', 'title': 'Mother, (AP) ZDV+sdNVP+TRV Tail', 'description': 'Mothers received ZDV+sdNVP+TRV tail', 'otherNumAtRisk': 1547, 'deathsNumAtRisk': 1547, 'otherNumAffected': 1413, 'seriousNumAtRisk': 1547, 'deathsNumAffected': 9, 'seriousNumAffected': 267}, {'id': 'EG001', 'title': 'Mother, (AP) Triple ARV (3TC-ZDV/LPV-RTV)', 'description': 'Mothers received Triple ARV (3TC-ZDV/LPV-RTV)', 'otherNumAtRisk': 1545, 'deathsNumAtRisk': 1545, 'otherNumAffected': 1414, 'seriousNumAtRisk': 1545, 'deathsNumAffected': 14, 'seriousNumAffected': 276}, {'id': 'EG002', 'title': 'Mother, (AP) Triple ARV (FTC-TDF/LPV-RTV)', 'description': 'Mothers received Triple ARV (FTC-TDF/LPV-RTV)', 'otherNumAtRisk': 445, 'deathsNumAtRisk': 445, 'otherNumAffected': 388, 'seriousNumAtRisk': 445, 'deathsNumAffected': 2, 'seriousNumAffected': 69}, {'id': 'EG003', 'title': 'Mother, LP', 'description': 'Registrational component to assess entry criteria for possible randomization in the Postpartum Component', 'otherNumAtRisk': 204, 'deathsNumAtRisk': 204, 'otherNumAffected': 169, 'seriousNumAtRisk': 204, 'deathsNumAffected': 3, 'seriousNumAffected': 10}, {'id': 'EG004', 'title': 'Infant, (Mother Received ZDV+sdNVP+TRV Tail)', 'description': 'Mothers received ZDV+sdNVP+TRV tail', 'otherNumAtRisk': 1500, 'deathsNumAtRisk': 1500, 'otherNumAffected': 1406, 'seriousNumAtRisk': 1500, 'deathsNumAffected': 59, 'seriousNumAffected': 296}, {'id': 'EG005', 'title': 'Infant, (Mother Received Triple ARV (3TC-ZDV/LPV-RTV))', 'description': 'Mothers received Triple ARV (3TC-ZDV/LPV-RTV)', 'otherNumAtRisk': 1478, 'deathsNumAtRisk': 1478, 'otherNumAffected': 1388, 'seriousNumAtRisk': 1478, 'deathsNumAffected': 46, 'seriousNumAffected': 287}, {'id': 'EG006', 'title': 'Infant, (Mother Received Triple ARV (FTC-TDF/LPV-RTV))', 'description': 'Mothers received Triple ARV (FTC-TDF/LPV-RTV)', 'otherNumAtRisk': 429, 'deathsNumAtRisk': 429, 'otherNumAffected': 403, 'seriousNumAtRisk': 429, 'deathsNumAffected': 27, 'seriousNumAffected': 113}, {'id': 'EG007', 'title': 'Infant, LP', 'description': 'Registrational component to assess entry criteria for possible randomization in the Postpartum Component', 'otherNumAtRisk': 204, 'deathsNumAtRisk': 204, 'otherNumAffected': 170, 'seriousNumAtRisk': 204, 'deathsNumAffected': 5, 'seriousNumAffected': 20}], 'otherEvents': [{'term': 'Iron deficiency anaemia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 34}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 33}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 3}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 10}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 96}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 81}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 6}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 18}], 'organSystem': 'Blood and lymphatic system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Congenital umbilical hernia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 93}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 89}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 34}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 4}], 'organSystem': 'Congenital, familial and genetic disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Eye discharge', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 7}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 6}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 2}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 99}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 94}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 11}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 13}], 'organSystem': 'Eye disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Abdominal pain', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 167}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 164}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 21}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 9}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 12}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 14}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 3}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 1}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Diarrhoea', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 179}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 202}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 41}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 5}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 307}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 317}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 52}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 16}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Gastritis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 72}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 63}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 24}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 13}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 2}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 2}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 1}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Vomiting', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 81}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 90}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 19}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 4}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 107}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 106}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 19}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 6}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Pyrexia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 118}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 92}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 26}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 4}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 260}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 240}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 48}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 18}], 'organSystem': 'General disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Body tinea', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 81}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 84}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 18}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 9}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 80}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 74}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 12}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 8}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Conjunctivitis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 37}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 30}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 10}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 6}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 99}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 75}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 20}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 8}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Gastroenteritis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 111}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 101}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 25}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 21}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 227}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 205}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 58}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 38}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Malaria', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 85}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 79}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 17}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 4}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 103}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 95}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 29}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 2}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Ophthalmia neonatorum', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 61}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 71}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 11}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 15}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Oral candidiasis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 13}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 8}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 1}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 124}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 112}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 44}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 14}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Otitis media acute', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 10}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 11}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 8}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 1}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 74}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 62}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 30}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 2}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Pharyngitis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 88}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 92}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 21}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 12}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 37}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 35}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 5}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 4}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Plasmodium falciparum infection', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 70}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 75}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 14}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 3}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 103}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 95}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 11}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 4}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Pneumonia bacterial', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 18}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 25}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 2}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 6}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 94}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 84}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 25}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 5}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Urinary tract infection', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 177}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 154}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 52}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 2}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 8}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 15}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 8}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Vulvovaginal candidiasis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 229}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 206}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 68}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 14}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 2}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 3}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Alanine aminotransferase increased', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 470}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 493}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 116}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 36}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 106}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 66}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 12}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 14}], 'organSystem': 'Investigations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Aspartate aminotransferase increased', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 68}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 88}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 29}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 12}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 4}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 3}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 1}], 'organSystem': 'Investigations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Blood albumin decreased', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 61}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 85}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 50}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 8}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 5}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 5}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 3}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Investigations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Haemoglobin decreased', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 764}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 791}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 191}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 103}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 1226}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 1230}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 356}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 124}], 'organSystem': 'Investigations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Hormone level abnormal', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 25}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 30}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 11}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 15}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Investigations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Neutrophil count decreased', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 668}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 619}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 161}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 67}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 859}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 848}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 255}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 115}], 'organSystem': 'Investigations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Platelet count decreased', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 151}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 144}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 41}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 18}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 94}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 94}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 40}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 9}], 'organSystem': 'Investigations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Weight decreased', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 112}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 85}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 21}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 10}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 29}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 20}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 16}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 2}], 'organSystem': 'Investigations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'White blood cell count decreased', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 66}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 54}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 15}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 12}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 12}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 4}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 3}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 1}], 'organSystem': 'Investigations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Failure to thrive', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 53}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 40}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 14}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 14}], 'organSystem': 'Metabolism and nutrition disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Growth failure', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 63}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 72}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 38}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 4}], 'organSystem': 'Musculoskeletal and connective tissue disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Headache', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 189}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 188}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 23}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 8}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Pregnancy', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 272}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 271}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 52}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 26}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Pregnancy, puerperium and perinatal conditions', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Dysuria', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 80}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 78}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 9}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 1}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 2}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 1}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Renal and urinary disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Vaginal discharge', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 116}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 136}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 21}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 5}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Reproductive system and breast disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Cough', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 179}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 173}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 20}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 6}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 274}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 253}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 35}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 17}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Dyspnoea', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 20}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 13}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 2}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 78}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 80}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 30}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 5}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Nasal congestion', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 81}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 93}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 12}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 1}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 144}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 138}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 23}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 8}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Rash', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 64}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 69}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 8}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 1}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 139}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 130}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 20}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 5}], 'organSystem': 'Skin and subcutaneous tissue disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Rash generalised', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 35}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 31}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 2}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 1}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 73}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 74}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 15}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 2}], 'organSystem': 'Skin and subcutaneous tissue disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Hypertension', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 119}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 120}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 27}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 18}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Vascular disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}], 'seriousEvents': [{'term': 'Anaemia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 13}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 16}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 4}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 3}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 10}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 11}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Blood and lymphatic system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Immune thrombocytopenic purpura', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Blood and lymphatic system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Iron deficiency anaemia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 1}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Blood and lymphatic system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Neutropenia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 4}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 2}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Blood and lymphatic system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Thrombocytopenia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Blood and lymphatic system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Extrasystoles', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Pulmonary valve stenosis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Ankyloglossia congenital', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Congenital, familial and genetic disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Atrial septal defect', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Congenital, familial and genetic disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Cleft palate', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 1}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Congenital, familial and genetic disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Congenital anaemia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Congenital, familial and genetic disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Congenital anomaly', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 1}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Congenital, familial and genetic disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Congenital genital malformation male', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Congenital, familial and genetic disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Congenital inguinal hernia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Congenital, familial and genetic disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Congenital malaria', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Congenital, familial and genetic disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Congenital megacolon', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 2}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Congenital, familial and genetic disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Congenital musculoskeletal anomaly', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Congenital, familial and genetic disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Congenital pneumonia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 2}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 3}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Congenital, familial and genetic disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Congenital rubella infection', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 1}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Congenital, familial and genetic disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Congenital syphilis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 2}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Congenital, familial and genetic disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Congenital umbilical hernia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Congenital, familial and genetic disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Craniosynostosis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Congenital, familial and genetic disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Dermoid cyst', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 1}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Congenital, familial and genetic disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Developmental hip dysplasia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 1}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Congenital, familial and genetic disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Exomphalos', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Congenital, familial and genetic disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Gastroschisis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Congenital, familial and genetic disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Genitalia external ambiguous', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Congenital, familial and genetic disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Heart disease congenital', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 1}], 'organSystem': 'Congenital, familial and genetic disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Holoprosencephaly', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Congenital, familial and genetic disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Hypospadias', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 2}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Congenital, familial and genetic disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Laryngomalacia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Congenital, familial and genetic disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Macrocephaly', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 1}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Congenital, familial and genetic disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Meningomyelocele', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 2}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 1}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Congenital, familial and genetic disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Micrognathia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Congenital, familial and genetic disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Multiple congenital abnormalities', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Congenital, familial and genetic disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Multiple gastrointestinal atresias', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Congenital, familial and genetic disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Patent ductus arteriosus', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 2}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 1}], 'organSystem': 'Congenital, familial and genetic disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Persistent foetal circulation', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Congenital, familial and genetic disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Sickle cell anaemia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Congenital, familial and genetic disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Talipes', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 2}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 1}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Congenital, familial and genetic disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Trisomy 21', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Congenital, familial and genetic disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Ventricular septal defect', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 1}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Congenital, familial and genetic disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Cataract', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 1}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Eye disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Conjunctival haemorrhage', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Eye disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Strabismus', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Eye disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Abdominal distension', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Abdominal mass', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Abdominal pain', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 4}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Abdominal pain lower', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 4}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Ascites', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Diarrhoea', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 3}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 3}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 3}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 1}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Femoral hernia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Gastritis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Haemorrhoids', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Ileus', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Ileus paralytic', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Intestinal obstruction', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 1}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Necrotising colitis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 6}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 3}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Peptic ulcer', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 1}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Rectal haemorrhage', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Small intestinal obstruction', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Umbilical hernia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Vomiting', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 1}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Death', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 4}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 4}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 3}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 1}], 'organSystem': 'General disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Infusion site extravasation', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'General disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Pyrexia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 2}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 3}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 4}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'General disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Sudden infant death syndrome', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'General disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Autoimmune hepatitis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Hepatobiliary disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Cholecystitis acute', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Hepatobiliary disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Drug-induced liver injury', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 3}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Hepatobiliary disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Hepatic function abnormal', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Hepatobiliary disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Hepatitis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 1}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Hepatobiliary disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Hepatotoxicity', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 2}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Hepatobiliary disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Hyperbilirubinaemia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Hepatobiliary disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Jaundice', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Hepatobiliary disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Jaundice cholestatic', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Hepatobiliary disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Abscess', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Abscess neck', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Amniotic cavity infection', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Anal abscess', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Appendicitis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Arthritis bacterial', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Bacteraemia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Bacterial infection', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Bacterial sepsis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 3}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 3}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 2}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': "Bartholin's abscess", 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 4}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 3}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Brain abscess', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Breast abscess', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 2}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Bronchiolitis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 8}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 8}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 1}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Bullous impetigo', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Cellulitis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Cervicitis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Conjunctivitis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Disseminated tuberculosis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Dysentery', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 2}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Encephalitis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 2}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Enterobacter sepsis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Gastroenteritis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 5}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 10}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 1}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 29}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 26}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 8}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 2}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Giardiasis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Lower respiratory tract infection', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 3}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 3}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 6}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 1}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Malaria', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 9}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 6}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 4}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 4}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 9}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 3}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 1}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Measles', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Meningitis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 1}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Meningitis bacterial', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 2}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Meningitis cryptococcal', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Meningitis tuberculous', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Meningitis viral', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Neonatal pneumonia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 2}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Neurosyphilis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Ophthalmia neonatorum', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 2}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 1}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Otitis media', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Pelvic abscess', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 1}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Pelvic infection', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Pelvic inflammatory disease', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 1}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Pertussis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Pharyngitis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Plasmodium falciparum infection', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 5}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 2}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 1}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 7}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 5}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Plasmodium malariae infection', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 1}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Pneumonia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 2}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 5}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 34}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 33}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 8}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 6}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Pneumonia bacterial', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 3}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 4}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 23}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 15}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 5}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Post procedural sepsis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Postoperative wound infection', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 1}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Postpartum sepsis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 3}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 2}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 1}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Pulmonary tuberculosis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 3}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 1}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Pyelonephritis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 2}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Respiratory tract infection', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Rhinitis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 2}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Salmonella sepsis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Salpingitis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Sepsis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 1}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 9}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 3}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 2}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Sepsis neonatal', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 47}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 33}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 11}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 3}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Sexually transmitted disease', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Staphylococcal scalded skin syndrome', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Staphylococcal sepsis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 1}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Staphylococcal skin infection', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Subcutaneous abscess', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Tuberculosis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Upper respiratory tract infection', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 1}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Urinary tract infection', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 12}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 8}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 4}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Vaginal infection', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 1}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Viral infection', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Vulvovaginitis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Vulvovaginitis trichomonal', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Wound infection', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 1}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Wound sepsis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Abdominal wound dehiscence', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 1}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Ankle fracture', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Bladder injury', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Burns first degree', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Burns second degree', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 1}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Clavicle fracture', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Femur fracture', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Forearm fracture', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Head injury', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 2}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 2}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Herbal toxicity', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Humerus fracture', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 1}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Lower limb fracture', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Multiple injuries', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Penetrating abdominal trauma', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Post procedural complication', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Postoperative wound complication', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Road traffic accident', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Soft tissue injury', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 2}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Thermal burn', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 2}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 3}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Traumatic fracture', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 1}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Uterine dehiscence', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 1}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Uterine rupture', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 2}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Vaginal laceration', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Wound dehiscence', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 2}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Alanine aminotransferase increased', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 5}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Investigations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Amniotic fluid volume decreased', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 4}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Investigations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Aspartate aminotransferase increased', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Investigations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Blood creatinine increased', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Investigations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Foetal non-stress test abnormal', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Investigations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Haemoglobin decreased', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 2}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Investigations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Hepatic enzyme increased', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 2}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 1}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Investigations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Liver function test increased', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Investigations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Neutrophil count decreased', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Investigations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Transaminases increased', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 2}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 1}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Investigations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Weight decreased', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Investigations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Dehydration', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Metabolism and nutrition disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Diabetes mellitus', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Metabolism and nutrition disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Diabetic ketoacidosis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Metabolism and nutrition disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Failure to thrive', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 1}], 'organSystem': 'Metabolism and nutrition disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Hypoglycaemia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 2}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Metabolism and nutrition disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Hypoglycaemia neonatal', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Metabolism and nutrition disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Malnutrition', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 22}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 20}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 11}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 2}], 'organSystem': 'Metabolism and nutrition disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Marasmus', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 1}], 'organSystem': 'Metabolism and nutrition disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Poor feeding infant', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Metabolism and nutrition disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Vitamin K deficiency', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 1}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Metabolism and nutrition disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Intervertebral disc protrusion', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Musculoskeletal and connective tissue disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Joint hyperextension', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Musculoskeletal and connective tissue disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Symphysiolysis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Musculoskeletal and connective tissue disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Aphasia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Cerebral infarction', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 1}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Cerebrovascular accident', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 1}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Convulsion neonatal', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 2}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Dizziness', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Encephalopathy neonatal', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Facial paralysis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Febrile convulsion', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 2}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Generalised tonic-clonic seizure', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Headache', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 2}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Hemiparesis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Hydrocephalus', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Hypoxic-ischaemic encephalopathy', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 2}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 2}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Migraine', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Seizure', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 2}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Abortion', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Pregnancy, puerperium and perinatal conditions', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Abortion complete', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Pregnancy, puerperium and perinatal conditions', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Abortion incomplete', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 4}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Pregnancy, puerperium and perinatal conditions', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Abortion missed', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 1}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Pregnancy, puerperium and perinatal conditions', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Abortion spontaneous', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 7}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 5}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 1}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Pregnancy, puerperium and perinatal conditions', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Abortion threatened', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 2}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 2}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Pregnancy, puerperium and perinatal conditions', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Eclampsia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 2}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 2}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Pregnancy, puerperium and perinatal conditions', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Ectopic pregnancy', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 2}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Pregnancy, puerperium and perinatal conditions', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'False labour', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 2}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 4}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Pregnancy, puerperium and perinatal conditions', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Foetal death', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 25}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 37}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 7}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 1}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Pregnancy, puerperium and perinatal conditions', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Foetal distress syndrome', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Pregnancy, puerperium and perinatal conditions', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Foetal growth restriction', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 5}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Pregnancy, puerperium and perinatal conditions', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Foetal hypokinesia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Pregnancy, puerperium and perinatal conditions', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Gestational diabetes', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 2}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Pregnancy, puerperium and perinatal conditions', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Gestational hypertension', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 18}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 9}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 6}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Pregnancy, puerperium and perinatal conditions', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'HELLP syndrome', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Pregnancy, puerperium and perinatal conditions', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Haemorrhage in pregnancy', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 9}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 4}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 1}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Pregnancy, puerperium and perinatal conditions', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Hyperemesis gravidarum', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 1}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Pregnancy, puerperium and perinatal conditions', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Intrapartum haemorrhage', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Pregnancy, puerperium and perinatal conditions', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Jaundice neonatal', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 6}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 2}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 1}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Pregnancy, puerperium and perinatal conditions', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Labour pain', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Pregnancy, puerperium and perinatal conditions', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Low birth weight baby', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 3}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 6}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 5}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Pregnancy, puerperium and perinatal conditions', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Meconium in amniotic fluid', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Pregnancy, puerperium and perinatal conditions', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Obstructed labour', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 1}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Pregnancy, puerperium and perinatal conditions', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Oligohydramnios', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 3}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 4}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 2}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Pregnancy, puerperium and perinatal conditions', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Peripartum cardiomyopathy', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Pregnancy, puerperium and perinatal conditions', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Placenta accreta', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 1}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Pregnancy, puerperium and perinatal conditions', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Placenta praevia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 2}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Pregnancy, puerperium and perinatal conditions', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Placental insufficiency', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Pregnancy, puerperium and perinatal conditions', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Polyhydramnios', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Pregnancy, puerperium and perinatal conditions', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Postpartum haemorrhage', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 11}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 11}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 2}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Pregnancy, puerperium and perinatal conditions', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Pre-eclampsia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 15}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 16}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 3}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Pregnancy, puerperium and perinatal conditions', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Premature baby', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 25}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 42}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 19}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Pregnancy, puerperium and perinatal conditions', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Premature delivery', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 9}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 4}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 3}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Pregnancy, puerperium and perinatal conditions', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Premature labour', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 16}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 15}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 8}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Pregnancy, puerperium and perinatal conditions', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Premature rupture of membranes', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 10}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 14}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 2}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Pregnancy, puerperium and perinatal conditions', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Premature separation of placenta', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 6}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 2}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 2}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Pregnancy, puerperium and perinatal conditions', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Preterm premature rupture of membranes', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 7}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 4}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 3}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Pregnancy, puerperium and perinatal conditions', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Prolonged labour', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 1}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Pregnancy, puerperium and perinatal conditions', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Prolonged pregnancy', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 1}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Pregnancy, puerperium and perinatal conditions', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Prolonged rupture of membranes', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 1}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Pregnancy, puerperium and perinatal conditions', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Retained placenta or membranes', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 2}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Pregnancy, puerperium and perinatal conditions', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Retained products of conception', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 6}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 4}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 2}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Pregnancy, puerperium and perinatal conditions', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Ruptured ectopic pregnancy', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 2}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Pregnancy, puerperium and perinatal conditions', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Small for dates baby', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 2}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Pregnancy, puerperium and perinatal conditions', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Stillbirth', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 5}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 9}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 1}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 1}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Pregnancy, puerperium and perinatal conditions', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Threatened labour', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 3}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 4}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Pregnancy, puerperium and perinatal conditions', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Umbilical cord around neck', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Pregnancy, puerperium and perinatal conditions', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Umbilical cord prolapse', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Pregnancy, puerperium and perinatal conditions', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Umbilical granuloma', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 1}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Pregnancy, puerperium and perinatal conditions', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Vomiting in pregnancy', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 1}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Pregnancy, puerperium and perinatal conditions', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Brief psychotic disorder, with postpartum onset', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Psychiatric disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Confusional state', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Psychiatric disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Conversion disorder', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Psychiatric disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Intentional self-injury', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 4}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Psychiatric disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Major depression', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Psychiatric disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Mental disorder', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Psychiatric disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Psychotic disorder', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 2}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Psychiatric disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Acute kidney injury', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Renal and urinary disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Anuria', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Renal and urinary disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Chronic kidney disease', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Renal and urinary disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Renal failure', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Renal and urinary disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Urinary retention', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Renal and urinary disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Adnexa uteri mass', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Reproductive system and breast disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Cervix disorder', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Reproductive system and breast disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Ovarian cyst', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Reproductive system and breast disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Uterine atony', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Reproductive system and breast disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Vaginal haemorrhage', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 3}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Reproductive system and breast disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Vulval haemorrhage', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Reproductive system and breast disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Acute respiratory distress syndrome', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Allergic respiratory disease', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Apnoea', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Asphyxia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Aspiration', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 2}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 3}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 1}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Asthma', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 3}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Dyspnoea', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 2}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Epistaxis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Hypoxia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 2}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Meconium aspiration syndrome', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 7}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 3}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 2}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Neonatal asphyxia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 11}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 4}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 10}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Neonatal respiratory distress syndrome', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 8}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 7}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 6}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Pneumonia aspiration', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Pneumothorax', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Pulmonary embolism', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Respiratory depression', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Respiratory distress', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 4}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 7}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 2}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Tachypnoea', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 1}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Transient tachypnoea of the newborn', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 5}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 4}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 2}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Upper airway obstruction', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Angioedema', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 2}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Skin and subcutaneous tissue disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Blister', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Skin and subcutaneous tissue disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Rash maculo-papular', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Skin and subcutaneous tissue disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Skin ulcer', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Skin and subcutaneous tissue disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Umbilical haemorrhage', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Skin and subcutaneous tissue disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Urticaria', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Skin and subcutaneous tissue disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Abortion induced', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 2}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Surgical and medical procedures', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Acrochordon excision', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Surgical and medical procedures', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Hospitalisation', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Surgical and medical procedures', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Infection prophylaxis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Surgical and medical procedures', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Psychosocial support', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Surgical and medical procedures', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Deep vein thrombosis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 2}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 1}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Vascular disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Haematoma', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Vascular disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Haemorrhage', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 1}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Vascular disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Hypertension', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 6}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 3}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Vascular disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Hypotension', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Vascular disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}, {'term': 'Subgaleal haematoma', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1547, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1545, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 445, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 204, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 1500, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 1478, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 429, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 204, 'numAffected': 0}], 'organSystem': 'Vascular disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA 20.0'}], 'frequencyThreshold': '5'}, 'outcomeMeasuresModule': {'outcomeMeasures': [{'type': 'PRIMARY', 'title': 'Antepartum Component: Number of Confirmed Infant HIV Infections', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1386', 'groupId': 'OG000'}, {'value': '1385', 'groupId': 'OG001'}, {'value': '325', 'groupId': 'OG002'}]}], 'groups': [{'id': 'OG000', 'title': 'Antepartum Arm A', 'description': 'Mothers Received ZDV+sdNVP+TRV Tail'}, {'id': 'OG001', 'title': 'Antepartum Arm B', 'description': 'Mothers received Triple ARV (3TC-ZDV/LPV-RTV)'}, {'id': 'OG002', 'title': 'Antepartum Arm C', 'description': 'Mothers Received Triple ARV (FTC-TDF/LPV-RTV)'}], 'classes': [{'categories': [{'measurements': [{'value': '25', 'groupId': 'OG000'}, {'value': '7', 'groupId': 'OG001'}, {'value': '2', 'groupId': 'OG002'}]}]}], 'analyses': [{'groupIds': ['OG000', 'OG001', 'OG002'], 'paramType': 'Risk Difference (RD)', 'ciNumSides': 'TWO_SIDED', 'ciPctValue': '96.5', 'paramValue': '-1.3', 'ciLowerLimit': '-2.1', 'ciUpperLimit': '-0.4', 'estimateComment': "The combination of Arm B and Arm C minus Arm A, based on a repeated confidence interval (Lan-DeMets approach with an O'Brien-Fleming type I error spending function to preserve an experiment-wise type I error rate of 5%).", 'groupDescription': 'Arm B and Arm C were combined and compared to Arm A. This comparison was an a priori planned comparison.', 'nonInferiorityType': 'SUPERIORITY'}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'timeFrame': 'Measured at birth or Week 1 study visit', 'description': 'Defined as HIV nucleic acid test (NAT) positivity of the specimen drawn at either the birth (Day 0-5) or Week 1 (Day 6-14) visit, confirmed by HIV NAT positivity of a second specimen collected at a different time point', 'unitOfMeasure': 'Participants', 'reportingStatus': 'POSTED', 'populationDescription': 'Analysis includes data from periods 1 and 2. Analysis is among the live births with HIV test results summarized for the maternal-infant set (the worst outcome summarized for cases of multiple births). Analysis used the principle of intent to treat.'}, {'type': 'PRIMARY', 'title': 'Antepartum Component: Number of Mothers With Grade 3 or Higher Toxicities and Selected Grade 2 Hematologic, Renal, and Hepatic Adverse Events', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1521', 'groupId': 'OG000'}, {'value': '1520', 'groupId': 'OG001'}, {'value': '424', 'groupId': 'OG002'}]}], 'groups': [{'id': 'OG000', 'title': 'Antepartum Arm A', 'description': 'Mothers received ZDV+sdNVP+TRV Tail'}, {'id': 'OG001', 'title': 'Antepartum Arm B', 'description': 'Mothers received Triple ARV (3TC-ZDV/LPV-RTV)'}, {'id': 'OG002', 'title': 'Antepartum Arm C', 'description': 'Mothers received Triple ARV (FTC-TDF/LPV-RTV)'}], 'classes': [{'title': 'Periods 1 and 2', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1510', 'groupId': 'OG000'}, {'value': '1505', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}]}], 'categories': [{'measurements': [{'value': '261', 'groupId': 'OG000'}, {'value': '318', 'groupId': 'OG001'}]}]}, {'title': 'Period 2', 'denoms': [{'units': 'Participants', 'counts': [{'value': '393', 'groupId': 'OG000'}, {'value': '385', 'groupId': 'OG001'}, {'value': '380', 'groupId': 'OG002'}]}], 'categories': [{'measurements': [{'value': '59', 'groupId': 'OG000'}, {'value': '61', 'groupId': 'OG001'}, {'value': '60', 'groupId': 'OG002'}]}]}], 'analyses': [{'pValue': '0.008', 'groupIds': ['OG000', 'OG001'], 'groupDescription': 'Periods 1 and 2', 'statisticalMethod': 'Fisher Exact', 'nonInferiorityType': 'SUPERIORITY'}, {'pValue': '0.77', 'groupIds': ['OG000', 'OG002'], 'groupDescription': 'Period 2', 'statisticalMethod': 'Fisher Exact', 'nonInferiorityType': 'SUPERIORITY'}, {'pValue': '>0.99', 'groupIds': ['OG001', 'OG002'], 'groupDescription': 'Period 2', 'statisticalMethod': 'Fisher Exact', 'nonInferiorityType': 'SUPERIORITY'}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'timeFrame': 'Measured through the Week 1 postpartum study visit', 'description': 'These events were graded using the Division of AIDS (DAIDS) AE Grading Table, Version 1.0, December 2004, Clarification August 2009, which is available on the RSC website (http://rsc.tech-res.com).', 'unitOfMeasure': 'Participants', 'reportingStatus': 'POSTED', 'populationDescription': 'Mothers with no safety data available after baseline were not included. Analysis used the principle of intent to treat.'}, {'type': 'PRIMARY', 'title': 'Antepartum Component: Number of Mothers With Obstetrical Complications', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1521', 'groupId': 'OG000'}, {'value': '1520', 'groupId': 'OG001'}, {'value': '424', 'groupId': 'OG002'}]}], 'groups': [{'id': 'OG000', 'title': 'Antepartum Arm A', 'description': 'Mothers received ZDV+sdNVP+TRV Tail'}, {'id': 'OG001', 'title': 'Antepartum Arm B', 'description': 'Mothers received Triple ARV (3TC-ZDV/LPV-RTV)'}, {'id': 'OG002', 'title': 'Antepartum Arm C', 'description': 'Mothers received Triple ARV (FTC-TDF/LPV-RTV)'}], 'classes': [{'title': 'Periods 1 and 2', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1521', 'groupId': 'OG000'}, {'value': '1510', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}]}], 'categories': [{'measurements': [{'value': '89', 'groupId': 'OG000'}, {'value': '75', 'groupId': 'OG001'}]}]}, {'title': 'Period 2', 'denoms': [{'units': 'Participants', 'counts': [{'value': '401', 'groupId': 'OG000'}, {'value': '398', 'groupId': 'OG001'}, {'value': '391', 'groupId': 'OG002'}]}], 'categories': [{'measurements': [{'value': '20', 'groupId': 'OG000'}, {'value': '12', 'groupId': 'OG001'}, {'value': '23', 'groupId': 'OG002'}]}]}], 'analyses': [{'pValue': '0.30', 'groupIds': ['OG000', 'OG001'], 'groupDescription': 'Periods 1 and 2', 'statisticalMethod': 'Fisher Exact', 'nonInferiorityType': 'SUPERIORITY'}, {'pValue': '0.64', 'groupIds': ['OG000', 'OG002'], 'groupDescription': 'Period 2', 'statisticalMethod': 'Fisher Exact', 'nonInferiorityType': 'SUPERIORITY'}, {'pValue': '0.06', 'groupIds': ['OG001', 'OG002'], 'groupDescription': 'Period 2', 'statisticalMethod': 'Fisher Exact', 'nonInferiorityType': 'SUPERIORITY'}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'timeFrame': 'Measured through the Week 1 postpartum study visit', 'description': 'Complications included deaths, diagnoses, signs/symptoms, chemistry lab tests, or hematological lab tests, with grades of 3 (Severe) or worse. Obstetrical complications were those classified by the MedDra coding system as "Pregnancy, puerperium and perinatal conditions", except if the condition was the death of the fetus: "Abortions not specified as induced or spontaneous", "Abortions spontaneous", or "Stillbirth and foetal death."', 'unitOfMeasure': 'Participants', 'reportingStatus': 'POSTED', 'populationDescription': 'Mothers who do not have any obstetrical complications information available after study entry are not included. Analysis used the principle of intent to treat.'}, {'type': 'PRIMARY', 'title': 'Antepartum Component: Number of Mothers With Adverse Pregnancy Outcomes (e.g.,Stillbirth, Preterm Delivery (< 37 Weeks), Low Birth Weight (< 2,500 Grams), and Congenital Anomalies)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1451', 'groupId': 'OG000'}, {'value': '1447', 'groupId': 'OG001'}, {'value': '372', 'groupId': 'OG002'}]}], 'groups': [{'id': 'OG000', 'title': 'Antepartum Arm A', 'description': 'Mothers received ZDV+sdNVP+TRV Tail'}, {'id': 'OG001', 'title': 'Antepartum Arm B', 'description': 'Mothers received Triple ARV (3TC-ZDV/LPV-RTV)'}, {'id': 'OG002', 'title': 'Antepartum Arm C', 'description': 'Mothers received Triple ARV (FTC-TDF/LPV-RTV)'}], 'classes': [{'title': 'Periods 1 and 2', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1451', 'groupId': 'OG000'}, {'value': '1447', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}]}], 'categories': [{'measurements': [{'value': '389', 'groupId': 'OG000'}, {'value': '563', 'groupId': 'OG001'}]}]}, {'title': 'Period 2', 'denoms': [{'units': 'Participants', 'counts': [{'value': '349', 'groupId': 'OG000'}, {'value': '348', 'groupId': 'OG001'}, {'value': '341', 'groupId': 'OG002'}]}], 'categories': [{'measurements': [{'value': '91', 'groupId': 'OG000'}, {'value': '123', 'groupId': 'OG001'}, {'value': '111', 'groupId': 'OG002'}]}]}], 'analyses': [{'pValue': '<0.001', 'groupIds': ['OG000', 'OG001'], 'groupDescription': 'Periods 1 and 2', 'statisticalMethod': 'Fisher Exact', 'nonInferiorityType': 'SUPERIORITY'}, {'pValue': '0.04', 'groupIds': ['OG000', 'OG002'], 'groupDescription': 'Period 2', 'statisticalMethod': 'Fisher Exact', 'nonInferiorityType': 'SUPERIORITY'}, {'pValue': '0.46', 'groupIds': ['OG001', 'OG002'], 'groupDescription': 'Period 2', 'statisticalMethod': 'Fisher Exact', 'nonInferiorityType': 'SUPERIORITY'}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'timeFrame': 'Measured at birth', 'description': 'Composite outcome', 'unitOfMeasure': 'Participants', 'reportingStatus': 'POSTED', 'populationDescription': 'Includes mothers with confirmed infant birth outcome as live birth, stillbirth, or spontaneous abortion and outcome assessments. Multiple gestation pregnancies (twins and triplets) were summarized at the unique mother level. Analysis used the principle of intent to treat.'}, {'type': 'PRIMARY', 'title': 'Postpartum Component: Incidence of Confirmed Infant HIV Infection', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1219', 'groupId': 'OG000'}, {'value': '1211', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'Postpartum Arm A (Maternal Prophylaxis)', 'description': 'Mothers received prophylaxis \\[preferred regimen: TRV + LPV-RTV\\]. Infants received short-course NVP.'}, {'id': 'OG001', 'title': 'Postpartum Arm B (Infant Prophylaxis)', 'description': 'Infants received extended NVP.'}], 'classes': [{'categories': [{'measurements': [{'value': '0.56', 'groupId': 'OG000'}, {'value': '0.55', 'groupId': 'OG001'}]}]}], 'analyses': [{'groupIds': ['OG000', 'OG001'], 'paramType': 'Hazard Ratio (HR)', 'ciNumSides': 'TWO_SIDED', 'ciPctValue': '96', 'paramValue': '1.0', 'ciLowerLimit': '0.3', 'ciUpperLimit': '3.1', 'estimateComment': 'The confidence interval was based on a repeated confidence interval.', 'nonInferiorityType': 'SUPERIORITY'}], 'paramType': 'NUMBER', 'timeFrame': 'Measured through site recommended duration of breastfeeding, complete cessation of breastfeeding or 18 months of age, whichever comes first', 'description': 'Defined as infant HIV NAT positivity of a specimen drawn at any post-randomization visit (i.e., any visit after the Week 1 \\[Day 6-14\\] visit), confirmed by HIV NAT positivity of a second specimen drawn at a different time point. Analyses were conducted at the Mother-Infant (M-I) pair level, hence the worst outcome for multiple births was counted as a single event.', 'unitOfMeasure': 'New cases per 100 person-years', 'reportingStatus': 'POSTED', 'populationDescription': 'All Mother-Infant (M-I) pairs, except 1 M-I pair where infant was infected at date of randomization, were included in the analyses. 35 M-I pairs with no post-randomization HIV test results were included and censored at the date of randomization in the analyses. Analyses were intent to treat.'}, {'type': 'PRIMARY', 'title': 'Postpartum Component: Incidence of Grade 3 or Higher Adverse Events and Selected Grade 2 Hematologic, Renal, and Hepatic Adverse Events', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1220', 'groupId': 'OG000'}, {'value': '1211', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'Postpartum Arm A (Maternal Prophylaxis)', 'description': 'Mothers received prophylaxis \\[preferred regimen: TRV + LPV-RTV\\]. Infants received short-course NVP.'}, {'id': 'OG001', 'title': 'Postpartum Arm B (Infant Prophylaxis)', 'description': 'Infants received extended NVP.'}], 'classes': [{'categories': [{'measurements': [{'value': '14.4', 'groupId': 'OG000'}, {'value': '14.1', 'groupId': 'OG001'}]}]}], 'analyses': [{'pValue': '0.98', 'groupIds': ['OG000', 'OG001'], 'statisticalMethod': 'Log Rank', 'nonInferiorityType': 'SUPERIORITY'}], 'paramType': 'NUMBER', 'timeFrame': 'Measured through site recommended duration of breastfeeding, complete cessation of breastfeeding or 18 months of age, whichever comes first', 'description': 'These events were graded using the Division of AIDS (DAIDS) AE Grading Table, Version 1.0, December 2004, Clarification August 2009, which is available on the RSC website (http://rsc.tech-res.com).', 'unitOfMeasure': 'New cases per 100 person-years', 'reportingStatus': 'POSTED', 'populationDescription': 'All mothers were included in the analyses. 15 mothers with no post-randomization data were included and censored at the date of randomization in the analyses. Analyses were intent to treat.'}, {'type': 'PRIMARY', 'title': 'Maternal Health Component: Incidence of Progression to AIDS-defining Illness or Death', 'denoms': [{'units': 'Participants', 'counts': [{'value': '797', 'groupId': 'OG000'}, {'value': '805', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'Maternal Health Arm A (Continue Triple ARVs)', 'description': 'Mothers continued receiving triple ARV regimen \\[preferred regimen: TRV + LPV-RTV\\].'}, {'id': 'OG001', 'title': 'Maternal Health Arm B (Discontinue Triple ARVs)', 'description': 'Mothers discontinued triple ARV regimen.'}], 'classes': [{'categories': [{'measurements': [{'value': '0.24', 'groupId': 'OG000'}, {'value': '0.49', 'groupId': 'OG001'}]}]}], 'analyses': [{'pValue': '0.37', 'groupIds': ['OG000', 'OG001'], 'paramType': 'Hazard Ratio (HR)', 'ciNumSides': 'TWO_SIDED', 'ciPctValue': '95', 'paramValue': '0.55', 'ciLowerLimit': '0.14', 'ciUpperLimit': '2.08', 'estimateComment': 'The hazard ratio compares Arm A relative to Arm B.', 'statisticalMethod': 'Log Rank', 'nonInferiorityType': 'SUPERIORITY'}], 'paramType': 'NUMBER', 'timeFrame': 'From study entry until July 7, 2015, an average of 94 weeks of follow-up.', 'description': 'AIDS-defining illness refers to the WHO Clinical Stage 4 illnesses in Appendix IV of the protocol. These events were reviewed and confirmed by an Endpoint review group.', 'unitOfMeasure': 'New cases per 100 person-years', 'reportingStatus': 'POSTED', 'populationDescription': 'This analysis includes mothers on HAART in the Antepartum component and who were eligible and randomized as part of the Postpartum Component or the Maternal Health Component. Analysis used the intent to treat principle.'}, {'type': 'SECONDARY', 'title': 'Antepartum Component: Number of Infant HIV Infections', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1386', 'groupId': 'OG000'}, {'value': '1385', 'groupId': 'OG001'}, {'value': '325', 'groupId': 'OG002'}]}], 'groups': [{'id': 'OG000', 'title': 'Antepartum Arm A', 'description': 'Mothers received ZDV+sdNVP+TRV Tail'}, {'id': 'OG001', 'title': 'Antepartum Arm B', 'description': 'Mothers received Triple ARV (3TC-ZDV/LPV-RTV)'}, {'id': 'OG002', 'title': 'Antepartum Arm C', 'description': 'Mothers received Triple ARV (FTC-TDF/LPV-RTV)'}], 'classes': [{'categories': [{'measurements': [{'value': '22', 'groupId': 'OG000'}, {'value': '4', 'groupId': 'OG001'}, {'value': '2', 'groupId': 'OG002'}]}]}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'timeFrame': 'Measured at the birth (<= 3 days postpartum) visit', 'description': 'Detected by HIV NAT positivity', 'unitOfMeasure': 'Participants', 'reportingStatus': 'POSTED', 'populationDescription': 'Analysis is among the live births with HIV test results summarized in the maternal-infant set (the worst outcome summarized for multiple births to the same mother). Analysis used the principle of intent to treat.'}, {'type': 'SECONDARY', 'title': 'Antepartum Component: Probability of Overall and HIV-free Infant Survival Until 104 Weeks of Age, by Antepartum Arm (in Conjunction With Infants in the Postpartum Component)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1475', 'groupId': 'OG000'}, {'value': '1459', 'groupId': 'OG001'}, {'value': '389', 'groupId': 'OG002'}]}], 'groups': [{'id': 'OG000', 'title': 'Antepartum Arm A', 'description': 'Mothers received ZDV+sdNVP+TRV tail'}, {'id': 'OG001', 'title': 'Antepartum Arm B', 'description': 'Mothers received Triple ARV (3TC-ZDV/LPV-RTV)'}, {'id': 'OG002', 'title': 'Antepartum Arm C', 'description': 'Mothers received Triple ARV (FTC-TDF/LPV-RTV)'}], 'classes': [{'title': 'Overall survival, Periods 1 & 2 group (arms A & B only)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1475', 'groupId': 'OG000'}, {'value': '1459', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}]}], 'categories': [{'measurements': [{'value': '0.959', 'groupId': 'OG000', 'lowerLimit': '0.948', 'upperLimit': '0.969'}, {'value': '0.967', 'groupId': 'OG001', 'lowerLimit': '0.955', 'upperLimit': '0.975'}]}]}, {'title': 'Overall survival, period 2 group', 'denoms': [{'units': 'Participants', 'counts': [{'value': '404', 'groupId': 'OG000'}, {'value': '399', 'groupId': 'OG001'}, {'value': '389', 'groupId': 'OG002'}]}], 'categories': [{'measurements': [{'value': '0.951', 'groupId': 'OG000', 'lowerLimit': '0.920', 'upperLimit': '0.970'}, {'value': '0.982', 'groupId': 'OG001', 'lowerLimit': '0.962', 'upperLimit': '0.991'}, {'value': '0.942', 'groupId': 'OG002', 'lowerLimit': '0.914', 'upperLimit': '0.962'}]}]}, {'title': 'HIV-free survival, Periods 1&2 group (arms A&B only)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1475', 'groupId': 'OG000'}, {'value': '1459', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}]}], 'categories': [{'measurements': [{'value': '0.937', 'groupId': 'OG000', 'lowerLimit': '0.923', 'upperLimit': '0.948'}, {'value': '0.947', 'groupId': 'OG001', 'lowerLimit': '0.933', 'upperLimit': '0.958'}]}]}, {'title': 'HIV-free survival, period 2 group', 'denoms': [{'units': 'Participants', 'counts': [{'value': '404', 'groupId': 'OG000'}, {'value': '399', 'groupId': 'OG001'}, {'value': '389', 'groupId': 'OG002'}]}], 'categories': [{'measurements': [{'value': '0.936', 'groupId': 'OG000', 'lowerLimit': '0.903', 'upperLimit': '0.958'}, {'value': '0.940', 'groupId': 'OG001', 'lowerLimit': '0.864', 'upperLimit': '0.975'}, {'value': '0.921', 'groupId': 'OG002', 'lowerLimit': '0.887', 'upperLimit': '0.946'}]}]}], 'analyses': [{'pValue': '0.16', 'groupIds': ['OG000', 'OG001'], 'groupDescription': 'Overall survival', 'statisticalMethod': 'Two-sided Z test', 'nonInferiorityType': 'SUPERIORITY'}, {'pValue': '0.0156', 'groupIds': ['OG000', 'OG001'], 'groupDescription': 'Overall survival, period 2 group', 'statisticalMethod': 'Two-sided Z test', 'nonInferiorityType': 'SUPERIORITY'}, {'pValue': '0.31', 'groupIds': ['OG000', 'OG002'], 'groupDescription': 'Overall survival, period 2 group', 'statisticalMethod': 'Two-sided Z test', 'nonInferiorityType': 'SUPERIORITY'}, {'pValue': '0.0022', 'groupIds': ['OG001', 'OG002'], 'groupDescription': 'Overall survival, period 2 group', 'statisticalMethod': 'Two-sided Z test', 'nonInferiorityType': 'SUPERIORITY'}, {'pValue': '0.13', 'groupIds': ['OG000', 'OG001'], 'groupDescription': 'HIV-free survival', 'statisticalMethod': 'Two-sided Z test', 'nonInferiorityType': 'SUPERIORITY'}, {'pValue': '0.44', 'groupIds': ['OG000', 'OG001'], 'groupDescription': 'HIV-free survival, period 2 group', 'statisticalMethod': 'Two-sided Z test', 'nonInferiorityType': 'SUPERIORITY'}, {'pValue': '0.24', 'groupIds': ['OG000', 'OG002'], 'groupDescription': 'HIV-free survival, period 2 group', 'statisticalMethod': 'Two-sided Z test', 'nonInferiorityType': 'SUPERIORITY'}, {'pValue': '0.26', 'groupIds': ['OG001', 'OG002'], 'groupDescription': 'HIV-free survival, group 2', 'statisticalMethod': 'Two-sided Z test', 'nonInferiorityType': 'SUPERIORITY'}], 'paramType': 'NUMBER', 'timeFrame': 'Measured from birth through 104 weeks of age', 'description': 'For overall survival, failure was defined to be death. For HIV-free survival, failure was defined to be either death or developing HIV. The probability of living, or living without HIV infection, at 104 weeks was calculated by Kaplan-Meier estimation of the survival function.', 'unitOfMeasure': 'Proportional probability', 'dispersionType': '95% Confidence Interval', 'reportingStatus': 'POSTED', 'populationDescription': 'Infants in the antepartum component not excluded from analysis; only one infant was included per pregnancy, the one with the earliest failure time. The Periods 1\\&2 group is infants born to mothers randomized in Arms A and B throughout the PROMISE study (both protocol versions). The period 2 group includes infants born to mothers randomized during the last protocol version only. Since Arm C was only available to all under the last protocol version, this enables unbiased comparison with Arm C.'}, {'type': 'SECONDARY', 'title': 'Antepartum Component: Maternal HIV RNA Less Than 400 Copies/mL at Delivery', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1547', 'groupId': 'OG000'}, {'value': '1545', 'groupId': 'OG001'}, {'value': '445', 'groupId': 'OG002'}]}], 'groups': [{'id': 'OG000', 'title': 'Antepartum Arm A', 'description': 'Mothers Received ZDV+sdNVP+TRV Tail'}, {'id': 'OG001', 'title': 'Antepartum Arm B', 'description': 'Mothers received Triple ARV (3TC-ZDV/LPV-RTV)'}, {'id': 'OG002', 'title': 'Antepartum Arm C', 'description': 'Mothers Received Triple ARV (FTC-TDF/LPV-RTV)'}], 'classes': [{'title': 'Periods 1 and 2', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1344', 'groupId': 'OG000'}, {'value': '1367', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}]}], 'categories': [{'title': 'HIV RNA < 400 copies/mL', 'measurements': [{'value': '415', 'groupId': 'OG000'}, {'value': '1092', 'groupId': 'OG001'}]}, {'title': 'HIV RNA >= 400 copies/mL', 'measurements': [{'value': '929', 'groupId': 'OG000'}, {'value': '275', 'groupId': 'OG001'}]}]}, {'title': 'Period 2', 'denoms': [{'units': 'Participants', 'counts': [{'value': '312', 'groupId': 'OG000'}, {'value': '321', 'groupId': 'OG001'}, {'value': '304', 'groupId': 'OG002'}]}], 'categories': [{'title': 'HIV RNA < 400 copies/mL', 'measurements': [{'value': '102', 'groupId': 'OG000'}, {'value': '259', 'groupId': 'OG001'}, {'value': '225', 'groupId': 'OG002'}]}, {'title': 'HIV RNA >= 400 copies/mL', 'measurements': [{'value': '210', 'groupId': 'OG000'}, {'value': '62', 'groupId': 'OG001'}, {'value': '79', 'groupId': 'OG002'}]}]}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'timeFrame': 'Measured at the time of delivery', 'description': 'Analysis used the principle of intent to treat.', 'unitOfMeasure': 'Participants', 'reportingStatus': 'POSTED', 'populationDescription': 'Analysis includes only mothers with HIV RNA data at delivery. Analysis used the principle of intent to treat.'}, {'type': 'SECONDARY', 'title': 'Postpartum Component: Proportion of Mother-Infant Pairs With no Death or HIV Diagnosis Through 24 Months Post-delivery', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1219', 'groupId': 'OG000'}, {'value': '1211', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'Postpartum Arm A (Maternal Prophylaxis)', 'description': 'Mothers received prophylaxis \\[preferred regimen: TRV + LPV-RTV\\]. Infants received short-course NVP.'}, {'id': 'OG001', 'title': 'Postpartum Arm B (Infant Prophylaxis)', 'description': 'Infants received extended NVP.'}], 'classes': [{'categories': [{'measurements': [{'value': '0.971', 'groupId': 'OG000', 'lowerLimit': '0.959', 'upperLimit': '0.980'}, {'value': '0.977', 'groupId': 'OG001', 'lowerLimit': '0.966', 'upperLimit': '0.985'}]}]}], 'paramType': 'NUMBER', 'timeFrame': 'Measured through 24 months post-delivery', 'description': 'Defined as infant HIV NAT positivity of a specimen drawn at any post-randomization visit, confirmed by HIV NAT positivity of a second specimen drawn at a different time point, or infant death. Analyses (Kaplan-Meier probabilities) were conducted at the Mother-Infant (M-I) pair level, hence the worst outcome for multiple births was counted as a single event.', 'unitOfMeasure': 'Probability', 'dispersionType': '95% Confidence Interval', 'reportingStatus': 'POSTED', 'populationDescription': 'All M-I pairs, except 1 M-I pair where infant was infected at date of randomization, were included in the analyses. 3 M-I pairs with no post-randomization data were included and censored at the date of randomization. Analyses were intent to treat.'}, {'type': 'SECONDARY', 'title': 'Postpartum Component: Proportion of Infants Alive Through 12 and 24 Months Post-delivery', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1227', 'groupId': 'OG000'}, {'value': '1217', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'Postpartum Arm A (Maternal Prophylaxis)', 'description': 'Mothers received prophylaxis \\[preferred regimen: TRV + LPV-RTV\\]. Infants received short-course NVP.'}, {'id': 'OG001', 'title': 'Postpartum Arm B (Infant Prophylaxis)', 'description': 'Infants received extended NVP.'}], 'classes': [{'title': '12 months post delivery', 'categories': [{'measurements': [{'value': '0.988', 'groupId': 'OG000', 'lowerLimit': '0.980', 'upperLimit': '0.993'}, {'value': '0.989', 'groupId': 'OG001', 'lowerLimit': '0.981', 'upperLimit': '0.994'}]}]}, {'title': '24 months post delivery', 'categories': [{'measurements': [{'value': '0.978', 'groupId': 'OG000', 'lowerLimit': '0.967', 'upperLimit': '0.986'}, {'value': '0.987', 'groupId': 'OG001', 'lowerLimit': '0.979', 'upperLimit': '0.992'}]}]}], 'paramType': 'NUMBER', 'timeFrame': 'Measured at 12 and 24 months post-delivery', 'description': 'Analyses (Kaplan-Meier probabilities) conducted for all individual infants (rather than M-I pair)', 'unitOfMeasure': 'Probability', 'dispersionType': '95% Confidence Interval', 'reportingStatus': 'POSTED', 'populationDescription': 'All live-born infants were included in the analyses. 4 infants with no post-randomization data were included and censored at the date of randomization in the analyses. Analyses were intent to treat.'}, {'type': 'SECONDARY', 'title': 'Maternal Health Component: Incidence of Death', 'denoms': [{'units': 'Participants', 'counts': [{'value': '797', 'groupId': 'OG000'}, {'value': '805', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'Maternal Health Arm A (Continue Triple ARVs)', 'description': 'Mothers continued receiving triple ARV regimen \\[preferred regimen: TRV + LPV-RTV\\].'}, {'id': 'OG001', 'title': 'Maternal Health Arm B (Discontinue Triple ARVs)', 'description': 'Mothers discontinued triple ARV regimen.'}], 'classes': [{'categories': [{'measurements': [{'value': '0.24', 'groupId': 'OG000', 'lowerLimit': '0.18', 'upperLimit': '0.32'}, {'value': '0.43', 'groupId': 'OG001', 'lowerLimit': '0.36', 'upperLimit': '0.52'}]}]}], 'paramType': 'NUMBER', 'timeFrame': 'From study entry until July 7, 2015, an average of 94 weeks of follow-up.', 'description': 'Number of women who died during the maternal health component; that is, who had been randomized to either continue or discontinue ART after risk of HIV vertical transmission through breastfeeding was over.', 'unitOfMeasure': 'New cases per 100 person-years', 'dispersionType': '95% Confidence Interval', 'reportingStatus': 'POSTED', 'populationDescription': 'This analysis includes mothers on HAART in the Antepartum component and who were eligible and randomized as part of the Postpartum Component or the Maternal Health Component. Analysis used the intent to treat principle.'}, {'type': 'SECONDARY', 'title': 'Maternal Health Component: Incidence of AIDS-defining Illness', 'denoms': [{'units': 'Participants', 'counts': [{'value': '797', 'groupId': 'OG000'}, {'value': '805', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'Maternal Health Arm A (Continue Triple ARVs)', 'description': 'Mothers continued receiving triple ARV regimen \\[preferred regimen: TRV + LPV-RTV\\].'}, {'id': 'OG001', 'title': 'Maternal Health Arm B (Discontinue Triple ARVs)', 'description': 'Mothers discontinued triple ARV regimen.'}], 'classes': [{'categories': [{'measurements': [{'value': '0.08', 'groupId': 'OG000', 'lowerLimit': '0.05', 'upperLimit': '0.12'}, {'value': '0.25', 'groupId': 'OG001', 'lowerLimit': '0.20', 'upperLimit': '0.30'}]}]}], 'paramType': 'NUMBER', 'timeFrame': 'From study entry until July 7, 2015, an average of 94 weeks of follow-up.', 'description': '"AIDS-defining illness" refers to the WHO Clinical Stage 4 illnesses listed in Appendix IV. Stage 4 illnesses were reviewed and confirmed by an Endpoint review group.', 'unitOfMeasure': 'New cases per 100 person-years', 'dispersionType': '95% Confidence Interval', 'reportingStatus': 'POSTED', 'populationDescription': 'This analysis includes mothers on HAART in the Antepartum component and who were eligible and randomized as part of the Postpartum Component or the Maternal Health Component. Analysis used the intent to treat principle.'}, {'type': 'SECONDARY', 'title': 'Maternal Health Component: Incidence of HIV/AIDS-related Events', 'denoms': [{'units': 'Participants', 'counts': [{'value': '797', 'groupId': 'OG000'}, {'value': '805', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'Maternal Health Arm A (Continue Triple ARVs)', 'description': 'Mothers continued receiving triple ARV regimen \\[preferred regimen: TRV + LPV-RTV\\].'}, {'id': 'OG001', 'title': 'Maternal Health Arm B (Discontinue Triple ARVs)', 'description': 'Mothers discontinued triple ARV regimen.'}], 'classes': [{'categories': [{'measurements': [{'value': '1.14', 'groupId': 'OG000', 'lowerLimit': '0.89', 'upperLimit': '1.45'}, {'value': '1.24', 'groupId': 'OG001', 'lowerLimit': '1.02', 'upperLimit': '1.52'}]}]}], 'paramType': 'NUMBER', 'timeFrame': 'From study entry until July 7, 2015, an average of 94 weeks of follow-up.', 'description': '"HIV/AIDS-related event" refers to the WHO Clinical Stage 4 illnesses, pulmonary tuberculosis, and other serious bacterial infections listed in Appendix IV of the protocol. Stage 4 illnesses were reviewed and confirmed by an Endpoint review group.', 'unitOfMeasure': 'New cases per 100 person-years', 'dispersionType': '95% Confidence Interval', 'reportingStatus': 'POSTED', 'populationDescription': 'This analysis includes mothers on HAART in the Antepartum component and who were eligible and randomized as part of the Postpartum Component or the Maternal Health Component. Analysis used the intent to treat principle.'}, {'type': 'SECONDARY', 'title': 'Maternal Health Component: Incidence Rate of Cardiovascular or Other Metabolic Events', 'denoms': [{'units': 'Participants', 'counts': [{'value': '794', 'groupId': 'OG000'}, {'value': '805', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'Maternal Health Arm A (Continue Triple ARVs)', 'description': 'Mothers continued receiving triple ARV regimen \\[preferred regimen: TRV + LPV-RTV\\].'}, {'id': 'OG001', 'title': 'Maternal Health Arm B (Discontinue Triple ARVs)', 'description': 'Mothers discontinued triple ARV regimen.'}], 'classes': [{'categories': [{'measurements': [{'value': '2.9', 'groupId': 'OG000', 'lowerLimit': '2.3', 'upperLimit': '3.8'}, {'value': '5.7', 'groupId': 'OG001', 'lowerLimit': '4.8', 'upperLimit': '6.7'}]}]}], 'paramType': 'NUMBER', 'timeFrame': 'From study entry until July 7, 2015, an average of 94 weeks of follow-up.', 'description': 'Cardiovascular or metabolic events of particular concern were included in this analysis. A Poisson model with time to first event as an offset and an over-dispersion parameter was used to estimate incidence rates.\n\nMetabolic events considered were diabetes mellitus, lipodystrophy, or dyslipidemia. Cardiovascular events considered were hypertension, congestive heart failure, stroke, Transient Ischemia Event (TIA), pulmonary embolism, myocardial infarction (whether acute symptomatic or silent), coronary artery disease, deep vein thrombosis, peripheral vascular disease, or symptomatic HIV-associated cardiomyopathy.', 'unitOfMeasure': 'events per 100 person-years', 'dispersionType': '95% Confidence Interval', 'reportingStatus': 'POSTED', 'populationDescription': 'This analysis includes mothers on HAART in the Antepartum component and who were eligible and randomized as part of the Postpartum Component or the Maternal Health Component. Analysis used the intent to treat principle.'}, {'type': 'SECONDARY', 'title': 'Maternal Health Component: Other Targeted Medical Conditions', 'denoms': [{'units': 'Participants', 'counts': [{'value': '794', 'groupId': 'OG000'}, {'value': '805', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'Maternal Health Arm A (Continue Triple ARVs)', 'description': 'Mothers continued receiving triple ARV regimen \\[preferred regimen: TRV + LPV-RTV\\].'}, {'id': 'OG001', 'title': 'Maternal Health Arm B (Discontinue Triple ARVs)', 'description': 'Mothers discontinued triple ARV regimen.'}], 'classes': [{'categories': [{'measurements': [{'value': '4.0', 'groupId': 'OG000', 'lowerLimit': '3.2', 'upperLimit': '4.9'}, {'value': '4.6', 'groupId': 'OG001', 'lowerLimit': '3.9', 'upperLimit': '5.5'}]}]}], 'paramType': 'NUMBER', 'timeFrame': 'From study entry until July 7, 2015, an average of 94 weeks of follow-up.', 'description': 'Other (non-cardiologic) medical conditions of particular concern were included in this outcome. A Poisson model with time to first event as an offset and an over-dispersion parameter was used to estimate incidence rates. Events included were metabolic events, hepatic events, renal events, infections such as pulmonary tuberculosis, malaria, or other serious bacterial infections, and others.', 'unitOfMeasure': 'events per 100 person-years', 'dispersionType': '95% Confidence Interval', 'reportingStatus': 'POSTED', 'populationDescription': 'This analysis includes mothers on HAART in the Antepartum component and who were eligible and randomized as part of the Postpartum Component or the Maternal Health Component. Analysis used the intent to treat principle.'}, {'type': 'SECONDARY', 'title': 'Maternal Health Component: Incidence of HIV/AIDS-related Event or Death', 'denoms': [{'units': 'Participants', 'counts': [{'value': '797', 'groupId': 'OG000'}, {'value': '805', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'Maternal Health Arm A (Continue Triple ARVs)', 'description': 'Mothers continued receiving triple ARV regimen \\[preferred regimen: TRV + LPV-RTV\\].'}, {'id': 'OG001', 'title': 'Maternal Health Arm B (Discontinue Triple ARVs)', 'description': 'Mothers discontinued triple ARV regimen.'}], 'classes': [{'categories': [{'measurements': [{'value': '1.30', 'groupId': 'OG000', 'lowerLimit': '1.03', 'upperLimit': '1.65'}, {'value': '1.43', 'groupId': 'OG001', 'lowerLimit': '1.17', 'upperLimit': '1.74'}]}]}], 'paramType': 'NUMBER', 'timeFrame': 'From study entry until July 7, 2015, an average of 94 weeks of follow-up.', 'description': '"HIV/AIDS-related event" refers to the WHO Clinical Stage 4 illnesses, pulmonary tuberculosis, and other serious bacterial infections listed in Appendix IV of the protocol. Stage 4 illnesses were reviewed and confirmed by an Endpoint review group.', 'unitOfMeasure': 'New cases per 100 person-years', 'dispersionType': '95% Confidence Interval', 'reportingStatus': 'POSTED', 'populationDescription': 'This analysis includes mothers on HAART in the Antepartum component and who were eligible and randomized as part of the Postpartum Component or the Maternal Health Component. Analysis used the intent to treat principle.'}, {'type': 'SECONDARY', 'title': 'Maternal Health Component: Incidence of HIV/AIDS-related Event or World Health Organization (WHO) Clinical Stage 2 or 3 Events', 'denoms': [{'units': 'Participants', 'counts': [{'value': '797', 'groupId': 'OG000'}, {'value': '805', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'Maternal Health Arm A (Continue Triple ARVs)', 'description': 'Mothers continued receiving triple ARV regimen \\[preferred regimen: TRV + LPV-RTV\\].'}, {'id': 'OG001', 'title': 'Maternal Health Arm B (Discontinue Triple ARVs)', 'description': 'Mothers discontinued triple ARV regimen.'}], 'classes': [{'categories': [{'measurements': [{'value': '3.47', 'groupId': 'OG000', 'lowerLimit': '2.80', 'upperLimit': '4.31'}, {'value': '5.61', 'groupId': 'OG001', 'lowerLimit': '4.83', 'upperLimit': '6.53'}]}]}], 'paramType': 'NUMBER', 'timeFrame': 'From study entry until July 7, 2015, an average of 94 weeks of follow-up.', 'description': '"HIV/AIDS-related event" refers to the WHO Clinical Stage 4 illnesses, pulmonary tuberculosis, and other serious bacterial infections listed in Appendix IV of the protocol. Stage 4 illnesses were reviewed and confirmed by an Endpoint review group.', 'unitOfMeasure': 'New cases per 100 person-years', 'dispersionType': '95% Confidence Interval', 'reportingStatus': 'POSTED', 'populationDescription': 'This analysis includes mothers on HAART in the Antepartum component and who were eligible and randomized as part of the Postpartum Component or the Maternal Health Component. Analysis used the intent to treat principle.'}, {'type': 'SECONDARY', 'title': 'Maternal Health Component: Incidence Rate of Death or Any Condition of Particular Concern', 'denoms': [{'units': 'Participants', 'counts': [{'value': '794', 'groupId': 'OG000'}, {'value': '805', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'Maternal Health Arm A (Continue Triple ARVs)', 'description': 'Mothers continued receiving triple ARV regimen \\[preferred regimen: TRV + LPV-RTV\\].'}, {'id': 'OG001', 'title': 'Maternal Health Arm B (Discontinue Triple ARVs)', 'description': 'Mothers discontinued triple ARV regimen.'}], 'classes': [{'categories': [{'measurements': [{'value': '9.0', 'groupId': 'OG000', 'lowerLimit': '7.3', 'upperLimit': '10.9'}, {'value': '14.0', 'groupId': 'OG001', 'lowerLimit': '12.1', 'upperLimit': '16.1'}]}]}], 'paramType': 'NUMBER', 'timeFrame': 'From study entry until July 7, 2015, an average of 94 weeks of follow-up.', 'description': 'Particular events were targeted as those of particular concern. This outcome considered all such events: death, events defining WHO stages II, III, or IV, targeted cardiovascular adverse events, other targeted adverse events, or cancers which were not AIDS-defining. A complete list can be found in Appendix IV of the Protocol. A Poisson model with time to first event as an offset and an over-dispersion parameter was used to estimate incidence rates.', 'unitOfMeasure': 'events per 100 person-years', 'dispersionType': '95% Confidence Interval', 'reportingStatus': 'POSTED', 'populationDescription': 'This analysis includes mothers on HAART in the Antepartum component and who were eligible and randomized as part of the Postpartum Component or the Maternal Health Component. Analysis used the intent to treat principle.'}, {'type': 'SECONDARY', 'title': 'Maternal Health Component: Incidence of Tuberculosis', 'denoms': [{'units': 'Participants', 'counts': [{'value': '797', 'groupId': 'OG000'}, {'value': '805', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'Maternal Health Arm A (Continue Triple ARVs)', 'description': 'Mothers continued receiving triple ARV regimen \\[preferred regimen: TRV + LPV-RTV\\].'}, {'id': 'OG001', 'title': 'Maternal Health Arm B (Discontinue Triple ARVs)', 'description': 'Mothers discontinued triple ARV regimen.'}], 'classes': [{'categories': [{'measurements': [{'value': '0.40', 'groupId': 'OG000', 'lowerLimit': '0.32', 'upperLimit': '0.51'}, {'value': '0.31', 'groupId': 'OG001', 'lowerLimit': '0.24', 'upperLimit': '0.39'}]}]}], 'paramType': 'NUMBER', 'timeFrame': 'From study entry until July 7, 2015, an average of 94 weeks of follow-up.', 'description': 'Incidence of tuberculosis.', 'unitOfMeasure': 'New cases per 100 person-years', 'dispersionType': '95% Confidence Interval', 'reportingStatus': 'POSTED', 'populationDescription': 'This analysis includes mothers on HAART in the Antepartum component and who were eligible and randomized as part of the Postpartum Component or the Maternal Health Component. Analysis used the intent to treat principle.'}, {'type': 'SECONDARY', 'title': 'Maternal Health Component: Toxicity: Incidence of Grade 3 or Greater Laboratory Results or Signs and Symptoms and Selected Grade 2 Hematologic, Renal, and Hepatic Laboratory Results', 'denoms': [{'units': 'Participants', 'counts': [{'value': '797', 'groupId': 'OG000'}, {'value': '805', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'Maternal Health Arm A (Continue Triple ARVs)', 'description': 'Mothers continued receiving triple ARV regimen \\[preferred regimen: TRV + LPV-RTV\\].'}, {'id': 'OG001', 'title': 'Maternal Health Arm B (Discontinue Triple ARVs)', 'description': 'Mothers discontinued triple ARV regimen.'}], 'classes': [{'categories': [{'measurements': [{'value': '15.3', 'groupId': 'OG000', 'lowerLimit': '12.8', 'upperLimit': '18.1'}, {'value': '13.9', 'groupId': 'OG001', 'lowerLimit': '11.9', 'upperLimit': '16.3'}]}]}], 'paramType': 'NUMBER', 'timeFrame': 'From study entry until July 7, 2015, an average of 94 weeks of follow-up.', 'description': 'The maternal safety endpoints summarized include grade 2, 3 or 4 hematologies (hemoglobin (Hb), White Blood Cells (WBC), Absolute Neutrophil Count (ANC), platelet count), chemistries (Alanine Aminotransferase (ALT or SGPT), serum creatinine), and grade 3 or 4 signs and symptoms that occurred post-randomization. These events were graded using the Division of AIDS (DAIDS) AE Grading Table, Version 1.0, December 2004, Clarification August 2009, which is available on the RSC website (http://rsc.tech-res.com).', 'unitOfMeasure': 'New cases per 100 person-years', 'dispersionType': '95% Confidence Interval', 'reportingStatus': 'POSTED', 'populationDescription': 'This analysis includes mothers on HAART in the Antepartum component and who were eligible and randomized as part of the Postpartum Component or the Maternal Health Component. Analysis used the intent to treat principle.'}, {'type': 'SECONDARY', 'title': 'Maternal Health Component: Incidence Rate of Progression to AIDS-defining Illness, Death, or a Serious Non-AIDS Cardiovascular, Hepatic, or Renal Event', 'denoms': [{'units': 'Participants', 'counts': [{'value': '794', 'groupId': 'OG000'}, {'value': '805', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'Maternal Health Arm A (Continue Triple ARVs)', 'description': 'Mothers continued receiving triple ARV regimen \\[preferred regimen: TRV + LPV-RTV\\].'}, {'id': 'OG001', 'title': 'Maternal Health Arm B (Discontinue Triple ARVs)', 'description': 'Mothers discontinued triple ARV regimen.'}], 'classes': [{'categories': [{'measurements': [{'value': '0.5', 'groupId': 'OG000', 'lowerLimit': '0.4', 'upperLimit': '0.6'}, {'value': '0.9', 'groupId': 'OG001', 'lowerLimit': '0.7', 'upperLimit': '1.0'}]}]}], 'paramType': 'NUMBER', 'timeFrame': 'From study entry until July 7, 2015, an average of 94 weeks of follow-up.', 'description': 'This outcome included AIDS-defining illnesses or cardiovascular, hepatic, or renal adverse events of particular concern which were evaluated as serious. Serious outcomes were both those defined as serious according to the International Conference on Harmonization (ICH) definition, or outcomes with grades equal to or worse than 3 ("Severe"). A Poisson model with time to first event as an offset and an over-dispersion parameter was used to estimate incidence rates. Cardiovascular events considered were hypertension, congestive heart failure, stroke, Transient Ischemia Event (TIA), pulmonary embolism, myocardial infarction (whether acute symptomatic or silent), coronary artery disease, deep vein thrombosis, peripheral vascular disease, or symptomatic HIV-associated cardiomyopathy. Hepatic events considered were cirrhosis and idiopathic sclerosing cholangitis. Renal events considered were renal insufficiency, acute or chronic.', 'unitOfMeasure': 'events per 100 person-years', 'dispersionType': '95% Confidence Interval', 'reportingStatus': 'POSTED', 'populationDescription': 'This analysis includes mothers on HAART in the Antepartum component and who were eligible and randomized as part of the Postpartum Component or the Maternal Health Component. Analysis used the intent to treat principle.'}, {'type': 'OTHER_PRE_SPECIFIED', 'title': 'Maternal Health Component: Cost-effectiveness', 'timeFrame': 'From study entry until July 7, 2015.', 'description': 'The protocol did not distinguish between outcomes essential to the primary publication and outcomes for subsequent publications of lesser priority. This outcome measure was listed as secondary in the protocol but the intention was as an exploratory outcome since cost-effectiveness was not a focus of the study.', 'reportingStatus': 'NOT_POSTED', 'denomUnitsSelected': 'Participants'}, {'type': 'OTHER_PRE_SPECIFIED', 'title': 'Maternal Health Component: Changes in Plasma Concentrations of Inflammatory and Thrombogenic Markers', 'timeFrame': 'From study entry until July 7, 2015.', 'description': 'The protocol did not distinguish between outcomes essential to the primary publication and outcomes for subsequent publications of lesser priority. This outcome measure was listed as secondary in the protocol but the intention was as an exploratory outcome since inflammation and thrombogenic markers were not a focus of the study.', 'reportingStatus': 'NOT_POSTED', 'denomUnitsSelected': 'Participants'}, {'type': 'OTHER_PRE_SPECIFIED', 'title': 'Maternal Health Component: Quality of Life', 'timeFrame': 'From study entry until July 7, 2015.', 'description': 'The protocol did not distinguish between outcomes essential to the primary publication and outcomes for subsequent publications of lesser priority. This outcome measure was listed as secondary in the protocol but the intention was as an exploratory outcome since quality of life was not a focus of the study.', 'reportingStatus': 'NOT_POSTED', 'denomUnitsSelected': 'Participants'}, {'type': 'OTHER_PRE_SPECIFIED', 'title': 'Maternal Health Component: Self-reported Adherence', 'timeFrame': 'From study entry until July 7, 2015.', 'description': 'The protocol did not distinguish between outcomes essential to the primary publication and outcomes for subsequent publications of lesser priority. This outcome measure was listed as secondary in the protocol but the intention was as an exploratory outcome since adherence was not a focus of the study.', 'reportingStatus': 'NOT_POSTED', 'denomUnitsSelected': 'Participants'}, {'type': 'OTHER_PRE_SPECIFIED', 'title': 'Maternal Health Component: Viral Resistance', 'timeFrame': 'From study entry until July 7, 2015.', 'description': 'The protocol did not distinguish between outcomes essential to the primary publication and outcomes for subsequent publications of lesser priority. This outcome measure was listed as secondary in the protocol but the intention was as an exploratory outcome since viral resistance was not a focus of the study.', 'reportingStatus': 'NOT_POSTED', 'denomUnitsSelected': 'Participants'}, {'type': 'OTHER_PRE_SPECIFIED', 'title': 'Postpartum Component: Functional Maternal Antibody and HIV-envelope Binding Responses in Breast Milk and Plasma, Until Cessation of Breastfeeding or 18 Months Postpartum, Whichever Comes First', 'timeFrame': 'Measured through the time of cessation of breastfeeding or 18 months postpartum, whichever comes first', 'description': 'The protocol did not distinguish between outcomes essential to the primary publication and outcomes for subsequent publications of lesser priority. This outcome measure was listed as secondary in the protocol but the intention was as an exploratory outcome since functional maternal antibody and HIV-envelope binding responses were not a focus of the study.', 'reportingStatus': 'NOT_POSTED', 'denomUnitsSelected': 'Participants'}, {'type': 'OTHER_PRE_SPECIFIED', 'title': 'Postpartum Component: Pharmacokinetic Parameters of ARV Drugs Measured in Maternal Plasma, Hair, Breast Milk, and Infant Blood (Plasma or Dried Blood Spot) Samples Collected at Birth; Weeks 1, 6, 14, and 26; and Subsequent Visits During Breastfeeding', 'timeFrame': 'Measured through the last study visit during breastfeeding, or 18 months postpartum, whichever comes first', 'description': 'The protocol did not distinguish between outcomes essential to the primary publication and outcomes for subsequent publications of lesser priority. This outcome measure was listed as secondary in the protocol but the intention was as an exploratory outcome since pharmacokinetics was not a focus of the study.', 'reportingStatus': 'NOT_POSTED', 'denomUnitsSelected': 'Participants'}, {'type': 'OTHER_PRE_SPECIFIED', 'title': 'Postpartum Component: Cost-effectiveness and Feasibility of the Study ARV Prophylaxis Regimens', 'timeFrame': 'Measured at the end of the 5-year study period', 'description': 'The protocol did not distinguish between outcomes essential to the primary publication and outcomes for subsequent publications of lesser priority. This outcome measure was listed as secondary in the protocol but the intention was as an exploratory outcome since cost-effectiveness was not a focus of the study.', 'reportingStatus': 'NOT_POSTED', 'denomUnitsSelected': 'Participants'}, {'type': 'OTHER_PRE_SPECIFIED', 'title': 'Postpartum Component: Rates and Patterns of Maternal and Infant Resistance to the Maternal and Infant ARV Regimens', 'timeFrame': 'Measured at the end of the 5-year study period', 'description': 'The protocol did not distinguish between outcomes essential to the primary publication and outcomes for subsequent publications of lesser priority. This outcome measure was listed as secondary in the protocol but the intention was as an exploratory outcome since viral resistance was not a focus of the study.', 'reportingStatus': 'NOT_POSTED', 'denomUnitsSelected': 'Participants'}, {'type': 'OTHER_PRE_SPECIFIED', 'title': 'Postpartum Component: Adherence to the Maternal and/or Infant ARV Regimens, as Measured by Maternal Report and Hair Measures', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1220', 'groupId': 'OG000'}, {'value': '1211', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'Postpartum Arm A (Maternal Prophylaxis)', 'description': 'Mothers received prophylaxis \\[preferred regimen: TRV + LPV-RTV\\]. Infants received short-course NVP.'}, {'id': 'OG001', 'title': 'Postpartum Arm B (Infant Prophylaxis)', 'description': 'Infants received extended NVP.'}], 'classes': [{'title': 'Week 6 visit', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1172', 'groupId': 'OG000'}, {'value': '1182', 'groupId': 'OG001'}]}], 'categories': [{'title': 'Never missed a dose', 'measurements': [{'value': '1003', 'groupId': 'OG000'}, {'value': '1104', 'groupId': 'OG001'}]}, {'title': 'Missed dose over 1 month ago', 'measurements': [{'value': '12', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}]}, {'title': 'Missed dose 2-4 weeks ago', 'measurements': [{'value': '17', 'groupId': 'OG000'}, {'value': '4', 'groupId': 'OG001'}]}, {'title': 'Missed dose within last 2 weeks', 'measurements': [{'value': '140', 'groupId': 'OG000'}, {'value': '74', 'groupId': 'OG001'}]}]}, {'title': 'Week 14 visit', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1123', 'groupId': 'OG000'}, {'value': '1140', 'groupId': 'OG001'}]}], 'categories': [{'title': 'Never missed a dose', 'measurements': [{'value': '956', 'groupId': 'OG000'}, {'value': '1081', 'groupId': 'OG001'}]}, {'title': 'Missed dose over 1 month ago', 'measurements': [{'value': '20', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}]}, {'title': 'Missed dose 2-4 weeks ago', 'measurements': [{'value': '35', 'groupId': 'OG000'}, {'value': '9', 'groupId': 'OG001'}]}, {'title': 'Missed dose within last 2 weeks', 'measurements': [{'value': '112', 'groupId': 'OG000'}, {'value': '50', 'groupId': 'OG001'}]}]}, {'title': 'Week 26 visit', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1070', 'groupId': 'OG000'}, {'value': '1091', 'groupId': 'OG001'}]}], 'categories': [{'title': 'Never missed a dose', 'measurements': [{'value': '888', 'groupId': 'OG000'}, {'value': '1035', 'groupId': 'OG001'}]}, {'title': 'Missed dose over 1 month ago', 'measurements': [{'value': '48', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}]}, {'title': 'Missed dose 2-4 weeks ago', 'measurements': [{'value': '31', 'groupId': 'OG000'}, {'value': '8', 'groupId': 'OG001'}]}, {'title': 'Missed dose within last 2 weeks', 'measurements': [{'value': '103', 'groupId': 'OG000'}, {'value': '47', 'groupId': 'OG001'}]}]}, {'title': 'Week 50 visit', 'denoms': [{'units': 'Participants', 'counts': [{'value': '851', 'groupId': 'OG000'}, {'value': '887', 'groupId': 'OG001'}]}], 'categories': [{'title': 'Never missed a dose', 'measurements': [{'value': '716', 'groupId': 'OG000'}, {'value': '841', 'groupId': 'OG001'}]}, {'title': 'Missed dose over 1 month ago', 'measurements': [{'value': '37', 'groupId': 'OG000'}, {'value': '9', 'groupId': 'OG001'}]}, {'title': 'Missed dose 2-4 weeks ago', 'measurements': [{'value': '34', 'groupId': 'OG000'}, {'value': '7', 'groupId': 'OG001'}]}, {'title': 'Missed dose within last 2 weeks', 'measurements': [{'value': '64', 'groupId': 'OG000'}, {'value': '30', 'groupId': 'OG001'}]}]}, {'title': 'Week 74 visit', 'denoms': [{'units': 'Participants', 'counts': [{'value': '377', 'groupId': 'OG000'}, {'value': '389', 'groupId': 'OG001'}]}], 'categories': [{'title': 'Never missed a dose', 'measurements': [{'value': '311', 'groupId': 'OG000'}, {'value': '377', 'groupId': 'OG001'}]}, {'title': 'Missed dose over 1 month ago', 'measurements': [{'value': '15', 'groupId': 'OG000'}, {'value': '2', 'groupId': 'OG001'}]}, {'title': 'Missed dose 2-4 weeks ago', 'measurements': [{'value': '17', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}]}, {'title': 'Missed dose within last 2 weeks', 'measurements': [{'value': '34', 'groupId': 'OG000'}, {'value': '9', 'groupId': 'OG001'}]}]}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'timeFrame': 'Week 6 visit (14 days - 9 weeks postpartum); Week 14 visit (10-19 weeks postpartum); Week 26 visit (20 to 31 weeks postpartum); Week 50 visit (44 to 55 weeks postpartum); and Week 74 visit (68 to 80 weeks postpartum).', 'description': 'Adherence is by maternal report; adherence through hair analysis is not included here.\n\nThe protocol did not distinguish between outcomes essential to the primary publication and outcomes for subsequent publications of lesser priority. This outcome measure was listed as secondary in the protocol but the intention was as an exploratory outcome since adherence was not a focus of the study.', 'unitOfMeasure': 'Participants', 'reportingStatus': 'POSTED', 'populationDescription': 'Women or infants in the postpartum component who had been included in the primary efficacy analysis (outcome measure #5 above), i.e., who had not yet reached the site recommended duration of breastfeeding, complete cessation of breastfeeding or 18 months of age, whichever comes first, and whose adherence questionnaire was filled out.'}, {'type': 'OTHER_PRE_SPECIFIED', 'title': 'Antepartum Component: Antepartum Change in HBV DNA Viral Load Between Week 8 and Baseline Levels (Using Log HBV DNA) Among Women With Detectable HBV DNA Viral Loads at Baseline and Other HBV Outcome Measures', 'timeFrame': 'Measured at Week 8', 'description': 'The protocol did not distinguish between outcomes essential to the primary publication and outcomes for subsequent publications of lesser priority. This outcome measure was listed as secondary in the protocol but the intention was as an exploratory outcome measure since changes in HBV DNA Viral Load was not a focus of the study.', 'reportingStatus': 'NOT_POSTED', 'denomUnitsSelected': 'Participants'}, {'type': 'OTHER_PRE_SPECIFIED', 'title': 'Antepartum Component: Cost Effectiveness and Feasibility of the Trial ARV Regimens', 'timeFrame': 'Measured at the end of the 5-year study period', 'description': 'The protocol did not distinguish between outcomes essential to the primary publication and outcomes for subsequent publications of lesser priority. This outcome measure was listed as secondary in the protocol but the intention was as an exploratory outcome measure since cost effectiveness was not a focus of the study.', 'reportingStatus': 'NOT_POSTED', 'denomUnitsSelected': 'Participants'}, {'type': 'OTHER_PRE_SPECIFIED', 'title': 'Antepartum Component: Maternal and Infant Viral Resistance to the Maternal and Infant ARV Strategies', 'timeFrame': 'Measured at the end of the 5-year study period', 'description': 'The protocol did not distinguish between outcomes essential to the primary publication and outcomes for subsequent publications of lesser priority. This outcome measure was listed as secondary in the protocol but the intention was as an exploratory outcome measure since viral resistance was not a focus of the study.', 'reportingStatus': 'NOT_POSTED', 'denomUnitsSelected': 'Participants'}, {'type': 'OTHER_PRE_SPECIFIED', 'title': 'Antepartum Component: Adherence to the Maternal Antiretroviral (ARV) Regimen, as Measured by Maternal Report', 'timeFrame': 'Measured through the Week 1 postpartum study visit', 'description': 'The protocol did not distinguish between outcomes essential to the primary publication and outcomes for subsequent publications of lesser priority. This outcome measure was listed as secondary in the protocol but the intention was as an exploratory outcome measure since adherence was not a focus of the study.', 'reportingStatus': 'NOT_POSTED', 'denomUnitsSelected': 'Participants'}]}, 'participantFlowModule': {'groups': [{'id': 'FG000', 'title': 'Antepartum Arm A', 'description': 'Mothers received ZDV+sdNVP+TRV tail'}, {'id': 'FG001', 'title': 'Antepartum Arm B', 'description': 'Mothers received Triple ARV (3TC-ZDV/LPV-RTV)'}, {'id': 'FG002', 'title': 'Antepartum Arm C', 'description': 'Mothers received Triple ARV (FTC-TDF/LPV-RTV)'}, {'id': 'FG003', 'title': 'Late Presenters', 'description': 'Registrational component to assess entry criteria for possible randomization in the Postpartum Component'}], 'periods': [{'title': 'Protocol Version 2.0: 04/2011-09/2012', 'milestones': [{'type': 'STARTED', 'achievements': [{'groupId': 'FG000', 'numSubjects': '855'}, {'groupId': 'FG001', 'numSubjects': '861'}, {'groupId': 'FG002', 'numSubjects': '25'}, {'groupId': 'FG003', 'numSubjects': '129'}]}, {'type': 'Mothers That Met All Inclusion Criteria', 'achievements': [{'groupId': 'FG000', 'numSubjects': '853'}, {'groupId': 'FG001', 'numSubjects': '861'}, {'groupId': 'FG002', 'numSubjects': '24'}, {'groupId': 'FG003', 'numSubjects': '129'}]}, {'type': 'COMPLETED', 'achievements': [{'groupId': 'FG000', 'numSubjects': '623'}, {'groupId': 'FG001', 'numSubjects': '620'}, {'groupId': 'FG002', 'numSubjects': '16'}, {'groupId': 'FG003', 'numSubjects': '101'}]}, {'type': 'NOT COMPLETED', 'achievements': [{'groupId': 'FG000', 'numSubjects': '232'}, {'groupId': 'FG001', 'numSubjects': '241'}, {'groupId': 'FG002', 'numSubjects': '9'}, {'groupId': 'FG003', 'numSubjects': '28'}]}], 'dropWithdraws': [{'type': 'Protocol Violation', 'reasons': [{'groupId': 'FG000', 'numSubjects': '2'}, {'groupId': 'FG001', 'numSubjects': '0'}, {'groupId': 'FG002', 'numSubjects': '0'}, {'groupId': 'FG003', 'numSubjects': '1'}]}, {'type': 'Death', 'reasons': [{'groupId': 'FG000', 'numSubjects': '6'}, {'groupId': 'FG001', 'numSubjects': '9'}, {'groupId': 'FG002', 'numSubjects': '1'}, {'groupId': 'FG003', 'numSubjects': '2'}]}, {'type': 'Withdrawal by Subject', 'reasons': [{'groupId': 'FG000', 'numSubjects': '89'}, {'groupId': 'FG001', 'numSubjects': '82'}, {'groupId': 'FG002', 'numSubjects': '2'}, {'groupId': 'FG003', 'numSubjects': '10'}]}, {'type': 'Lost to Follow-up', 'reasons': [{'groupId': 'FG000', 'numSubjects': '73'}, {'groupId': 'FG001', 'numSubjects': '65'}, {'groupId': 'FG002', 'numSubjects': '2'}, {'groupId': 'FG003', 'numSubjects': '10'}]}, {'type': 'Site Closure', 'reasons': [{'groupId': 'FG000', 'numSubjects': '15'}, {'groupId': 'FG001', 'numSubjects': '19'}, {'groupId': 'FG002', 'numSubjects': '1'}, {'groupId': 'FG003', 'numSubjects': '0'}]}, {'type': 'Subject Unable to Get to Clinic', 'reasons': [{'groupId': 'FG000', 'numSubjects': '44'}, {'groupId': 'FG001', 'numSubjects': '61'}, {'groupId': 'FG002', 'numSubjects': '2'}, {'groupId': 'FG003', 'numSubjects': '5'}]}, {'type': 'Other Reason', 'reasons': [{'groupId': 'FG000', 'numSubjects': '3'}, {'groupId': 'FG001', 'numSubjects': '5'}, {'groupId': 'FG002', 'numSubjects': '1'}, {'groupId': 'FG003', 'numSubjects': '0'}]}]}, {'title': 'Protocol Version 3.0: 10/2012-10/2014', 'milestones': [{'type': 'STARTED', 'achievements': [{'groupId': 'FG000', 'numSubjects': '694'}, {'groupId': 'FG001', 'numSubjects': '686'}, {'groupId': 'FG002', 'numSubjects': '422'}, {'groupId': 'FG003', 'numSubjects': '75'}]}, {'type': 'Mothers That Met All Inclusion Criteria', 'achievements': [{'groupId': 'FG000', 'numSubjects': '694'}, {'groupId': 'FG001', 'numSubjects': '684'}, {'groupId': 'FG002', 'numSubjects': '421'}, {'groupId': 'FG003', 'numSubjects': '75'}]}, {'type': 'COMPLETED', 'achievements': [{'groupId': 'FG000', 'numSubjects': '542'}, {'groupId': 'FG001', 'numSubjects': '548'}, {'groupId': 'FG002', 'numSubjects': '345'}, {'groupId': 'FG003', 'numSubjects': '55'}]}, {'type': 'NOT COMPLETED', 'achievements': [{'groupId': 'FG000', 'numSubjects': '152'}, {'groupId': 'FG001', 'numSubjects': '138'}, {'groupId': 'FG002', 'numSubjects': '77'}, {'groupId': 'FG003', 'numSubjects': '20'}]}], 'dropWithdraws': [{'type': 'Protocol Violation', 'reasons': [{'groupId': 'FG000', 'numSubjects': '0'}, {'groupId': 'FG001', 'numSubjects': '0'}, {'groupId': 'FG002', 'numSubjects': '2'}, {'groupId': 'FG003', 'numSubjects': '4'}]}, {'type': 'Adverse Event', 'reasons': [{'groupId': 'FG000', 'numSubjects': '1'}, {'groupId': 'FG001', 'numSubjects': '0'}, {'groupId': 'FG002', 'numSubjects': '0'}, {'groupId': 'FG003', 'numSubjects': '0'}]}, {'type': 'Death', 'reasons': [{'groupId': 'FG000', 'numSubjects': '3'}, {'groupId': 'FG001', 'numSubjects': '5'}, {'groupId': 'FG002', 'numSubjects': '1'}, {'groupId': 'FG003', 'numSubjects': '1'}]}, {'type': 'Withdrawal by Subject', 'reasons': [{'groupId': 'FG000', 'numSubjects': '54'}, {'groupId': 'FG001', 'numSubjects': '52'}, {'groupId': 'FG002', 'numSubjects': '31'}, {'groupId': 'FG003', 'numSubjects': '3'}]}, {'type': 'Lost to Follow-up', 'reasons': [{'groupId': 'FG000', 'numSubjects': '49'}, {'groupId': 'FG001', 'numSubjects': '36'}, {'groupId': 'FG002', 'numSubjects': '25'}, {'groupId': 'FG003', 'numSubjects': '4'}]}, {'type': 'Site Closure', 'reasons': [{'groupId': 'FG000', 'numSubjects': '12'}, {'groupId': 'FG001', 'numSubjects': '11'}, {'groupId': 'FG002', 'numSubjects': '2'}, {'groupId': 'FG003', 'numSubjects': '0'}]}, {'type': 'Subject Unable to Get to Clinic', 'reasons': [{'groupId': 'FG000', 'numSubjects': '28'}, {'groupId': 'FG001', 'numSubjects': '26'}, {'groupId': 'FG002', 'numSubjects': '15'}, {'groupId': 'FG003', 'numSubjects': '5'}]}, {'type': 'Other Reason', 'reasons': [{'groupId': 'FG000', 'numSubjects': '5'}, {'groupId': 'FG001', 'numSubjects': '8'}, {'groupId': 'FG002', 'numSubjects': '1'}, {'groupId': 'FG003', 'numSubjects': '3'}]}]}], 'recruitmentDetails': 'From April 2011 to October 2014, pregnant or just-delivered women were recruited at medical centers in low-income countries.'}, 'baselineCharacteristicsModule': {'denoms': [{'units': 'Participants', 'counts': [{'value': '1547', 'groupId': 'BG000'}, {'value': '1545', 'groupId': 'BG001'}, {'value': '445', 'groupId': 'BG002'}, {'value': '204', 'groupId': 'BG003'}, {'value': '3741', 'groupId': 'BG004'}]}], 'groups': [{'id': 'BG000', 'title': 'Antepartum Arm A', 'description': 'Mothers received ZDV+sdNVP+TRV tail'}, {'id': 'BG001', 'title': 'Antepartum Arm B', 'description': 'Mothers received Triple ARV (3TC-ZDV/LPV-RTV)'}, {'id': 'BG002', 'title': 'Antepartum Arm C', 'description': 'Mothers received Triple ARV (FTC-TDF/LPV-RTV)'}, {'id': 'BG003', 'title': 'Late Presenters', 'description': 'Registrational component to assess entry criteria for possible randomization in the Postpartum Component'}, {'id': 'BG004', 'title': 'Total', 'description': 'Total of all reporting groups'}], 'measures': [{'title': 'Age, Continuous', 'classes': [{'denoms': [{'units': 'Participants', 'counts': [{'value': '1547', 'groupId': 'BG000'}, {'value': '1545', 'groupId': 'BG001'}, {'value': '445', 'groupId': 'BG002'}, {'value': '204', 'groupId': 'BG003'}, {'value': '3741', 'groupId': 'BG004'}]}], 'categories': [{'measurements': [{'value': '26.5', 'groupId': 'BG000', 'lowerLimit': '22.8', 'upperLimit': '30.1'}, {'value': '26.6', 'groupId': 'BG001', 'lowerLimit': '23.3', 'upperLimit': '30.3'}, {'value': '26.4', 'groupId': 'BG002', 'lowerLimit': '22.7', 'upperLimit': '30.4'}, {'value': '26.8', 'groupId': 'BG003', 'lowerLimit': '23.2', 'upperLimit': '31.1'}, {'value': '26.5', 'groupId': 'BG004', 'lowerLimit': '23.0', 'upperLimit': '30.3'}]}]}], 'paramType': 'MEDIAN', 'unitOfMeasure': 'years', 'dispersionType': 'INTER_QUARTILE_RANGE'}, {'title': 'Sex: Female, Male', 'classes': [{'denoms': [{'units': 'Participants', 'counts': [{'value': '1547', 'groupId': 'BG000'}, {'value': '1545', 'groupId': 'BG001'}, {'value': '445', 'groupId': 'BG002'}, {'value': '204', 'groupId': 'BG003'}, {'value': '3741', 'groupId': 'BG004'}]}], 'categories': [{'title': 'Female', 'measurements': [{'value': '1547', 'groupId': 'BG000'}, {'value': '1545', 'groupId': 'BG001'}, {'value': '445', 'groupId': 'BG002'}, {'value': '204', 'groupId': 'BG003'}, {'value': '3741', 'groupId': 'BG004'}]}, {'title': 'Male', 'measurements': [{'value': '0', 'groupId': 'BG000'}, {'value': '0', 'groupId': 'BG001'}, {'value': '0', 'groupId': 'BG002'}, {'value': '0', 'groupId': 'BG003'}, {'value': '0', 'groupId': 'BG004'}]}]}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'unitOfMeasure': 'Participants'}, {'title': 'Race/Ethnicity, Customized', 'classes': [{'title': 'Black Non-Hispanic', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1547', 'groupId': 'BG000'}, {'value': '1545', 'groupId': 'BG001'}, {'value': '445', 'groupId': 'BG002'}, {'value': '204', 'groupId': 'BG003'}, {'value': '3741', 'groupId': 'BG004'}]}], 'categories': [{'measurements': [{'value': '1493', 'groupId': 'BG000'}, {'value': '1487', 'groupId': 'BG001'}, {'value': '440', 'groupId': 'BG002'}, {'value': '183', 'groupId': 'BG003'}, {'value': '3603', 'groupId': 'BG004'}]}]}, {'title': 'Hispanic (Regardless of Race)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1547', 'groupId': 'BG000'}, {'value': '1545', 'groupId': 'BG001'}, {'value': '445', 'groupId': 'BG002'}, {'value': '204', 'groupId': 'BG003'}, {'value': '3741', 'groupId': 'BG004'}]}], 'categories': [{'measurements': [{'value': '7', 'groupId': 'BG000'}, {'value': '12', 'groupId': 'BG001'}, {'value': '4', 'groupId': 'BG002'}, {'value': '2', 'groupId': 'BG003'}, {'value': '25', 'groupId': 'BG004'}]}]}, {'title': 'Asian, Pacific Islander', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1547', 'groupId': 'BG000'}, {'value': '1545', 'groupId': 'BG001'}, {'value': '445', 'groupId': 'BG002'}, {'value': '204', 'groupId': 'BG003'}, {'value': '3741', 'groupId': 'BG004'}]}], 'categories': [{'measurements': [{'value': '47', 'groupId': 'BG000'}, {'value': '46', 'groupId': 'BG001'}, {'value': '1', 'groupId': 'BG002'}, {'value': '19', 'groupId': 'BG003'}, {'value': '113', 'groupId': 'BG004'}]}]}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'unitOfMeasure': 'Participants'}, {'title': 'Region of Enrollment', 'classes': [{'title': 'Malawi', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1547', 'groupId': 'BG000'}, {'value': '1545', 'groupId': 'BG001'}, {'value': '445', 'groupId': 'BG002'}, {'value': '204', 'groupId': 'BG003'}, {'value': '3741', 'groupId': 'BG004'}]}], 'categories': [{'measurements': [{'value': '489', 'groupId': 'BG000'}, {'value': '493', 'groupId': 'BG001'}, {'value': '155', 'groupId': 'BG002'}, {'value': '31', 'groupId': 'BG003'}, {'value': '1168', 'groupId': 'BG004'}]}]}, {'title': 'Tanzania', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1547', 'groupId': 'BG000'}, {'value': '1545', 'groupId': 'BG001'}, {'value': '445', 'groupId': 'BG002'}, {'value': '204', 'groupId': 'BG003'}, {'value': '3741', 'groupId': 'BG004'}]}], 'categories': [{'measurements': [{'value': '23', 'groupId': 'BG000'}, {'value': '24', 'groupId': 'BG001'}, {'value': '10', 'groupId': 'BG002'}, {'value': '0', 'groupId': 'BG003'}, {'value': '57', 'groupId': 'BG004'}]}]}, {'title': 'South Africa', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1547', 'groupId': 'BG000'}, {'value': '1545', 'groupId': 'BG001'}, {'value': '445', 'groupId': 'BG002'}, {'value': '204', 'groupId': 'BG003'}, {'value': '3741', 'groupId': 'BG004'}]}], 'categories': [{'measurements': [{'value': '513', 'groupId': 'BG000'}, {'value': '510', 'groupId': 'BG001'}, {'value': '78', 'groupId': 'BG002'}, {'value': '27', 'groupId': 'BG003'}, {'value': '1128', 'groupId': 'BG004'}]}]}, {'title': 'Uganda', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1547', 'groupId': 'BG000'}, {'value': '1545', 'groupId': 'BG001'}, {'value': '445', 'groupId': 'BG002'}, {'value': '204', 'groupId': 'BG003'}, {'value': '3741', 'groupId': 'BG004'}]}], 'categories': [{'measurements': [{'value': '207', 'groupId': 'BG000'}, {'value': '205', 'groupId': 'BG001'}, {'value': '85', 'groupId': 'BG002'}, {'value': '9', 'groupId': 'BG003'}, {'value': '506', 'groupId': 'BG004'}]}]}, {'title': 'Zimbabwe', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1547', 'groupId': 'BG000'}, {'value': '1545', 'groupId': 'BG001'}, {'value': '445', 'groupId': 'BG002'}, {'value': '204', 'groupId': 'BG003'}, {'value': '3741', 'groupId': 'BG004'}]}], 'categories': [{'measurements': [{'value': '237', 'groupId': 'BG000'}, {'value': '236', 'groupId': 'BG001'}, {'value': '99', 'groupId': 'BG002'}, {'value': '116', 'groupId': 'BG003'}, {'value': '688', 'groupId': 'BG004'}]}]}, {'title': 'Zambia', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1547', 'groupId': 'BG000'}, {'value': '1545', 'groupId': 'BG001'}, {'value': '445', 'groupId': 'BG002'}, {'value': '204', 'groupId': 'BG003'}, {'value': '3741', 'groupId': 'BG004'}]}], 'categories': [{'measurements': [{'value': '32', 'groupId': 'BG000'}, {'value': '31', 'groupId': 'BG001'}, {'value': '18', 'groupId': 'BG002'}, {'value': '2', 'groupId': 'BG003'}, {'value': '83', 'groupId': 'BG004'}]}]}, {'title': 'India', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1547', 'groupId': 'BG000'}, {'value': '1545', 'groupId': 'BG001'}, {'value': '445', 'groupId': 'BG002'}, {'value': '204', 'groupId': 'BG003'}, {'value': '3741', 'groupId': 'BG004'}]}], 'categories': [{'measurements': [{'value': '46', 'groupId': 'BG000'}, {'value': '46', 'groupId': 'BG001'}, {'value': '0', 'groupId': 'BG002'}, {'value': '19', 'groupId': 'BG003'}, {'value': '111', 'groupId': 'BG004'}]}]}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'unitOfMeasure': 'Participants'}, {'title': 'Weight', 'classes': [{'denoms': [{'units': 'Participants', 'counts': [{'value': '1547', 'groupId': 'BG000'}, {'value': '1545', 'groupId': 'BG001'}, {'value': '445', 'groupId': 'BG002'}, {'value': '200', 'groupId': 'BG003'}, {'value': '3737', 'groupId': 'BG004'}]}], 'categories': [{'measurements': [{'value': '64', 'groupId': 'BG000', 'lowerLimit': '57.5', 'upperLimit': '73.5'}, {'value': '64.6', 'groupId': 'BG001', 'lowerLimit': '58', 'upperLimit': '74.1'}, {'value': '64.4', 'groupId': 'BG002', 'lowerLimit': '58', 'upperLimit': '75.9'}, {'value': '60.9', 'groupId': 'BG003', 'lowerLimit': '53', 'upperLimit': '68.9'}, {'value': '64', 'groupId': 'BG004', 'lowerLimit': '57.5', 'upperLimit': '74'}]}]}], 'paramType': 'MEDIAN', 'unitOfMeasure': 'kg', 'dispersionType': 'INTER_QUARTILE_RANGE', 'populationDescription': 'Some late presenters had incomplete measurements'}, {'title': 'BMI', 'classes': [{'denoms': [{'units': 'Participants', 'counts': [{'value': '1545', 'groupId': 'BG000'}, {'value': '1535', 'groupId': 'BG001'}, {'value': '442', 'groupId': 'BG002'}, {'value': '198', 'groupId': 'BG003'}, {'value': '3720', 'groupId': 'BG004'}]}], 'categories': [{'measurements': [{'value': '25.9', 'groupId': 'BG000', 'lowerLimit': '23.5', 'upperLimit': '29.5'}, {'value': '26.3', 'groupId': 'BG001', 'lowerLimit': '23.4', 'upperLimit': '29.8'}, {'value': '26.3', 'groupId': 'BG002', 'lowerLimit': '23.5', 'upperLimit': '30.1'}, {'value': '23.6', 'groupId': 'BG003', 'lowerLimit': '21.8', 'upperLimit': '26.8'}, {'value': '26', 'groupId': 'BG004', 'lowerLimit': '23.4', 'upperLimit': '29.6'}]}]}], 'paramType': 'MEDIAN', 'unitOfMeasure': 'kg/m^2', 'dispersionType': 'INTER_QUARTILE_RANGE', 'populationDescription': 'Some participants had incomplete measurements for either weight, height, or both.'}, {'title': 'HIV RNA level prior to randomization', 'classes': [{'denoms': [{'units': 'Participants', 'counts': [{'value': '1540', 'groupId': 'BG000'}, {'value': '1542', 'groupId': 'BG001'}, {'value': '445', 'groupId': 'BG002'}, {'value': '196', 'groupId': 'BG003'}, {'value': '3723', 'groupId': 'BG004'}]}], 'categories': [{'measurements': [{'value': '6409', 'groupId': 'BG000', 'lowerLimit': '1450.5', 'upperLimit': '22720'}, {'value': '8002', 'groupId': 'BG001', 'lowerLimit': '1854', 'upperLimit': '28767'}, {'value': '8393', 'groupId': 'BG002', 'lowerLimit': '1909', 'upperLimit': '28454'}, {'value': '12140', 'groupId': 'BG003', 'lowerLimit': '2407.5', 'upperLimit': '39138.5'}, {'value': '7409', 'groupId': 'BG004', 'lowerLimit': '1708', 'upperLimit': '26350'}]}]}], 'paramType': 'MEDIAN', 'unitOfMeasure': 'copies/ml', 'dispersionType': 'INTER_QUARTILE_RANGE', 'populationDescription': 'Baseline HIV RNA data was incomplete for some participants.'}, {'title': 'Viral Load at enrollment', 'classes': [{'denoms': [{'units': 'Participants', 'counts': [{'value': '1540', 'groupId': 'BG000'}, {'value': '1542', 'groupId': 'BG001'}, {'value': '445', 'groupId': 'BG002'}, {'value': '196', 'groupId': 'BG003'}, {'value': '3723', 'groupId': 'BG004'}]}], 'categories': [{'measurements': [{'value': '3.8', 'groupId': 'BG000', 'lowerLimit': '3.2', 'upperLimit': '4.4'}, {'value': '3.9', 'groupId': 'BG001', 'lowerLimit': '3.3', 'upperLimit': '4.5'}, {'value': '3.9', 'groupId': 'BG002', 'lowerLimit': '3.3', 'upperLimit': '4.5'}, {'value': '4.1', 'groupId': 'BG003', 'lowerLimit': '3.4', 'upperLimit': '4.6'}, {'value': '3.9', 'groupId': 'BG004', 'lowerLimit': '3.2', 'upperLimit': '4.4'}]}]}], 'paramType': 'MEDIAN', 'unitOfMeasure': 'log10 copies/mL', 'dispersionType': 'INTER_QUARTILE_RANGE', 'populationDescription': 'Baseline HIV RNA data was incomplete for some participants.'}, {'title': 'CD4 count at screening', 'classes': [{'denoms': [{'units': 'Participants', 'counts': [{'value': '1547', 'groupId': 'BG000'}, {'value': '1545', 'groupId': 'BG001'}, {'value': '445', 'groupId': 'BG002'}, {'value': '204', 'groupId': 'BG003'}, {'value': '3741', 'groupId': 'BG004'}]}], 'categories': [{'measurements': [{'value': '534', 'groupId': 'BG000', 'lowerLimit': '435', 'upperLimit': '678'}, {'value': '526', 'groupId': 'BG001', 'lowerLimit': '439', 'upperLimit': '651'}, {'value': '538', 'groupId': 'BG002', 'lowerLimit': '434', 'upperLimit': '684'}, {'value': '520', 'groupId': 'BG003', 'lowerLimit': '353', 'upperLimit': '723'}, {'value': '530', 'groupId': 'BG004', 'lowerLimit': '434', 'upperLimit': '670'}]}]}], 'paramType': 'MEDIAN', 'unitOfMeasure': 'cells/mm^3', 'dispersionType': 'INTER_QUARTILE_RANGE'}, {'title': 'ALT (SGPT)', 'classes': [{'denoms': [{'units': 'Participants', 'counts': [{'value': '1547', 'groupId': 'BG000'}, {'value': '1545', 'groupId': 'BG001'}, {'value': '445', 'groupId': 'BG002'}, {'value': '196', 'groupId': 'BG003'}, {'value': '3733', 'groupId': 'BG004'}]}], 'categories': [{'measurements': [{'value': '12', 'groupId': 'BG000', 'lowerLimit': '10', 'upperLimit': '16'}, {'value': '12', 'groupId': 'BG001', 'lowerLimit': '9', 'upperLimit': '15'}, {'value': '12', 'groupId': 'BG002', 'lowerLimit': '9', 'upperLimit': '15'}, {'value': '16.5', 'groupId': 'BG003', 'lowerLimit': '12', 'upperLimit': '22'}, {'value': '12', 'groupId': 'BG004', 'lowerLimit': '10', 'upperLimit': '16'}]}]}], 'paramType': 'MEDIAN', 'unitOfMeasure': 'units/liter', 'dispersionType': 'INTER_QUARTILE_RANGE', 'populationDescription': 'Baseline Alanine Aminotransferase (ALT) values were incomplete for some late presenters.'}, {'title': 'Hemoglobin', 'classes': [{'denoms': [{'units': 'Participants', 'counts': [{'value': '1547', 'groupId': 'BG000'}, {'value': '1545', 'groupId': 'BG001'}, {'value': '445', 'groupId': 'BG002'}, {'value': '204', 'groupId': 'BG003'}, {'value': '3741', 'groupId': 'BG004'}]}], 'categories': [{'measurements': [{'value': '11', 'groupId': 'BG000', 'lowerLimit': '10.2', 'upperLimit': '11.8'}, {'value': '11.1', 'groupId': 'BG001', 'lowerLimit': '10.3', 'upperLimit': '11.8'}, {'value': '11', 'groupId': 'BG002', 'lowerLimit': '10.3', 'upperLimit': '11.8'}, {'value': '10.6', 'groupId': 'BG003', 'lowerLimit': '9.5', 'upperLimit': '11.7'}, {'value': '11', 'groupId': 'BG004', 'lowerLimit': '10.2', 'upperLimit': '11.8'}]}]}], 'paramType': 'MEDIAN', 'unitOfMeasure': 'g/dl', 'dispersionType': 'INTER_QUARTILE_RANGE'}, {'title': 'WBC', 'classes': [{'denoms': [{'units': 'Participants', 'counts': [{'value': '1547', 'groupId': 'BG000'}, {'value': '1545', 'groupId': 'BG001'}, {'value': '445', 'groupId': 'BG002'}, {'value': '196', 'groupId': 'BG003'}, {'value': '3733', 'groupId': 'BG004'}]}], 'categories': [{'measurements': [{'value': '6800', 'groupId': 'BG000', 'lowerLimit': '5670', 'upperLimit': '8200'}, {'value': '6900', 'groupId': 'BG001', 'lowerLimit': '5700', 'upperLimit': '8200'}, {'value': '6840', 'groupId': 'BG002', 'lowerLimit': '5700', 'upperLimit': '7900'}, {'value': '8660', 'groupId': 'BG003', 'lowerLimit': '6895', 'upperLimit': '10755'}, {'value': '6900', 'groupId': 'BG004', 'lowerLimit': '5700', 'upperLimit': '8250'}]}]}], 'paramType': 'MEDIAN', 'unitOfMeasure': '(cells/mm^3)', 'dispersionType': 'INTER_QUARTILE_RANGE', 'populationDescription': 'Baseline White Blood Cell (WBC) values were incomplete for some participants.'}, {'title': 'Absolute Neutrophil Count at Baseline', 'classes': [{'denoms': [{'units': 'Participants', 'counts': [{'value': '1547', 'groupId': 'BG000'}, {'value': '1545', 'groupId': 'BG001'}, {'value': '445', 'groupId': 'BG002'}, {'value': '196', 'groupId': 'BG003'}, {'value': '3733', 'groupId': 'BG004'}]}], 'categories': [{'measurements': [{'value': '4140', 'groupId': 'BG000', 'lowerLimit': '3250', 'upperLimit': '5360'}, {'value': '4209', 'groupId': 'BG001', 'lowerLimit': '3297', 'upperLimit': '5300'}, {'value': '3990', 'groupId': 'BG002', 'lowerLimit': '3220', 'upperLimit': '4990'}, {'value': '5680', 'groupId': 'BG003', 'lowerLimit': '4342.5', 'upperLimit': '7662.5'}, {'value': '4220', 'groupId': 'BG004', 'lowerLimit': '3297', 'upperLimit': '5400'}]}]}], 'paramType': 'MEDIAN', 'unitOfMeasure': 'cells/mm^3', 'dispersionType': 'INTER_QUARTILE_RANGE', 'populationDescription': 'Baseline Absolute Neutrophil Count (ANC) values were incomplete for some participants.'}, {'title': 'Platelet count', 'classes': [{'denoms': [{'units': 'Participants', 'counts': [{'value': '1547', 'groupId': 'BG000'}, {'value': '1544', 'groupId': 'BG001'}, {'value': '444', 'groupId': 'BG002'}, {'value': '195', 'groupId': 'BG003'}, {'value': '3730', 'groupId': 'BG004'}]}], 'categories': [{'measurements': [{'value': '238000', 'groupId': 'BG000', 'lowerLimit': '200000', 'upperLimit': '282000'}, {'value': '236000', 'groupId': 'BG001', 'lowerLimit': '196000', 'upperLimit': '282000'}, {'value': '242500', 'groupId': 'BG002', 'lowerLimit': '203000', 'upperLimit': '290000'}, {'value': '255000', 'groupId': 'BG003', 'lowerLimit': '217000', 'upperLimit': '321000'}, {'value': '239000', 'groupId': 'BG004', 'lowerLimit': '200000', 'upperLimit': '285000'}]}]}], 'paramType': 'MEDIAN', 'unitOfMeasure': 'cells/mm^3', 'dispersionType': 'INTER_QUARTILE_RANGE', 'populationDescription': 'Baseline platelet counts were incomplete for some participants.'}, {'title': 'Serum Creatinine', 'classes': [{'denoms': [{'units': 'Participants', 'counts': [{'value': '1547', 'groupId': 'BG000'}, {'value': '1545', 'groupId': 'BG001'}, {'value': '445', 'groupId': 'BG002'}, {'value': '199', 'groupId': 'BG003'}, {'value': '3736', 'groupId': 'BG004'}]}], 'categories': [{'measurements': [{'value': '0.5', 'groupId': 'BG000', 'lowerLimit': '0.4', 'upperLimit': '0.6'}, {'value': '0.5', 'groupId': 'BG001', 'lowerLimit': '0.4', 'upperLimit': '0.6'}, {'value': '0.5', 'groupId': 'BG002', 'lowerLimit': '0.4', 'upperLimit': '0.6'}, {'value': '0.6', 'groupId': 'BG003', 'lowerLimit': '0.5', 'upperLimit': '0.6'}, {'value': '0.5', 'groupId': 'BG004', 'lowerLimit': '0.4', 'upperLimit': '0.6'}]}]}], 'paramType': 'MEDIAN', 'unitOfMeasure': 'mg/dL', 'dispersionType': 'INTER_QUARTILE_RANGE', 'populationDescription': 'Baseline Serum Creatinine values were incomplete for some participants.'}, {'title': 'WHO Clinical Staging of HIV/AIDS', 'classes': [{'denoms': [{'units': 'Participants', 'counts': [{'value': '1544', 'groupId': 'BG000'}, {'value': '1542', 'groupId': 'BG001'}, {'value': '445', 'groupId': 'BG002'}, {'value': '169', 'groupId': 'BG003'}, {'value': '3700', 'groupId': 'BG004'}]}], 'categories': [{'title': 'Clinical stage I', 'measurements': [{'value': '1493', 'groupId': 'BG000'}, {'value': '1506', 'groupId': 'BG001'}, {'value': '434', 'groupId': 'BG002'}, {'value': '165', 'groupId': 'BG003'}, {'value': '3598', 'groupId': 'BG004'}]}, {'title': 'Clinical stage II', 'measurements': [{'value': '50', 'groupId': 'BG000'}, {'value': '34', 'groupId': 'BG001'}, {'value': '11', 'groupId': 'BG002'}, {'value': '4', 'groupId': 'BG003'}, {'value': '99', 'groupId': 'BG004'}]}, {'title': 'Clinical stage III', 'measurements': [{'value': '1', 'groupId': 'BG000'}, {'value': '2', 'groupId': 'BG001'}, {'value': '0', 'groupId': 'BG002'}, {'value': '0', 'groupId': 'BG003'}, {'value': '3', 'groupId': 'BG004'}]}]}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'description': 'Clinical staging of HIV/AIDS by WHO definitions (WHO, 2007). Staging is based on clinical findings that guide the diagnosis, evaluation, and management of HIV/AIDS. Clinical stages are categorized as 1 through 4, progressing from primary HIV infection to advanced HIV/AIDS. These stages are defined by specific clinical conditions or symptoms as described in the reference.', 'unitOfMeasure': 'Participants', 'populationDescription': 'Baseline WHO staging category was incomplete for some participants.'}, {'title': 'Calculated Creatinine Clearance (ml/min)', 'classes': [{'denoms': [{'units': 'Participants', 'counts': [{'value': '1547', 'groupId': 'BG000'}, {'value': '1545', 'groupId': 'BG001'}, {'value': '445', 'groupId': 'BG002'}, {'value': '199', 'groupId': 'BG003'}, {'value': '3736', 'groupId': 'BG004'}]}], 'categories': [{'title': '<= 50 ml/min', 'measurements': [{'value': '0', 'groupId': 'BG000'}, {'value': '0', 'groupId': 'BG001'}, {'value': '0', 'groupId': 'BG002'}, {'value': '1', 'groupId': 'BG003'}, {'value': '1', 'groupId': 'BG004'}]}, {'title': '> 50 - 60 ml/min', 'measurements': [{'value': '1', 'groupId': 'BG000'}, {'value': '0', 'groupId': 'BG001'}, {'value': '1', 'groupId': 'BG002'}, {'value': '1', 'groupId': 'BG003'}, {'value': '3', 'groupId': 'BG004'}]}, {'title': '> 60 - 80 ml/min', 'measurements': [{'value': '5', 'groupId': 'BG000'}, {'value': '5', 'groupId': 'BG001'}, {'value': '2', 'groupId': 'BG002'}, {'value': '2', 'groupId': 'BG003'}, {'value': '14', 'groupId': 'BG004'}]}, {'title': '> 80 - 100 ml/min', 'measurements': [{'value': '27', 'groupId': 'BG000'}, {'value': '31', 'groupId': 'BG001'}, {'value': '6', 'groupId': 'BG002'}, {'value': '10', 'groupId': 'BG003'}, {'value': '74', 'groupId': 'BG004'}]}, {'title': '> 100 - 120 ml/min', 'measurements': [{'value': '90', 'groupId': 'BG000'}, {'value': '108', 'groupId': 'BG001'}, {'value': '39', 'groupId': 'BG002'}, {'value': '31', 'groupId': 'BG003'}, {'value': '268', 'groupId': 'BG004'}]}, {'title': '> 120 ml/min', 'measurements': [{'value': '1424', 'groupId': 'BG000'}, {'value': '1401', 'groupId': 'BG001'}, {'value': '397', 'groupId': 'BG002'}, {'value': '154', 'groupId': 'BG003'}, {'value': '3376', 'groupId': 'BG004'}]}]}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'unitOfMeasure': 'Participants', 'populationDescription': 'Baseline Calculated Creatinine Clearance values were incomplete for some participants'}, {'title': 'Gestational age at study entry (weeks)', 'classes': [{'denoms': [{'units': 'Participants', 'counts': [{'value': '1547', 'groupId': 'BG000'}, {'value': '1544', 'groupId': 'BG001'}, {'value': '445', 'groupId': 'BG002'}, {'value': '194', 'groupId': 'BG003'}, {'value': '3730', 'groupId': 'BG004'}]}], 'categories': [{'measurements': [{'value': '25.7', 'groupId': 'BG000', 'lowerLimit': '20.9', 'upperLimit': '30.3'}, {'value': '25.2', 'groupId': 'BG001', 'lowerLimit': '20.6', 'upperLimit': '30.1'}, {'value': '26', 'groupId': 'BG002', 'lowerLimit': '21.9', 'upperLimit': '31.1'}, {'value': '38.6', 'groupId': 'BG003', 'lowerLimit': '37.3', 'upperLimit': '40'}, {'value': '25.6', 'groupId': 'BG004', 'lowerLimit': '21.1', 'upperLimit': '30.4'}]}]}], 'paramType': 'MEDIAN', 'unitOfMeasure': 'weeks', 'dispersionType': 'INTER_QUARTILE_RANGE', 'populationDescription': 'Baseline gestational age was incomplete for some participants.'}, {'title': 'Gestational age at study entry', 'classes': [{'denoms': [{'units': 'Participants', 'counts': [{'value': '1547', 'groupId': 'BG000'}, {'value': '1544', 'groupId': 'BG001'}, {'value': '445', 'groupId': 'BG002'}, {'value': '10', 'groupId': 'BG003'}, {'value': '3546', 'groupId': 'BG004'}]}], 'categories': [{'title': '<14 weeks', 'measurements': [{'value': '10', 'groupId': 'BG000'}, {'value': '8', 'groupId': 'BG001'}, {'value': '2', 'groupId': 'BG002'}, {'value': '0', 'groupId': 'BG003'}, {'value': '20', 'groupId': 'BG004'}]}, {'title': '14 - <28 weeks', 'measurements': [{'value': '956', 'groupId': 'BG000'}, {'value': '1008', 'groupId': 'BG001'}, {'value': '264', 'groupId': 'BG002'}, {'value': '0', 'groupId': 'BG003'}, {'value': '2228', 'groupId': 'BG004'}]}, {'title': '28 - <34 weeks', 'measurements': [{'value': '418', 'groupId': 'BG000'}, {'value': '368', 'groupId': 'BG001'}, {'value': '116', 'groupId': 'BG002'}, {'value': '1', 'groupId': 'BG003'}, {'value': '903', 'groupId': 'BG004'}]}, {'title': '34 - < 37 weeks', 'measurements': [{'value': '117', 'groupId': 'BG000'}, {'value': '113', 'groupId': 'BG001'}, {'value': '45', 'groupId': 'BG002'}, {'value': '0', 'groupId': 'BG003'}, {'value': '275', 'groupId': 'BG004'}]}, {'title': '>= 37 weeks', 'measurements': [{'value': '46', 'groupId': 'BG000'}, {'value': '47', 'groupId': 'BG001'}, {'value': '18', 'groupId': 'BG002'}, {'value': '9', 'groupId': 'BG003'}, {'value': '120', 'groupId': 'BG004'}]}]}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'unitOfMeasure': 'Participants', 'populationDescription': 'Baseline gestational age was incomplete for some participants.'}, {'title': 'The Most Complex ARV Regimen for Prior PMTCT', 'classes': [{'denoms': [{'units': 'Participants', 'counts': [{'value': '1539', 'groupId': 'BG000'}, {'value': '1544', 'groupId': 'BG001'}, {'value': '445', 'groupId': 'BG002'}, {'value': '204', 'groupId': 'BG003'}, {'value': '3732', 'groupId': 'BG004'}]}], 'categories': [{'title': 'HAART including NNRTI', 'measurements': [{'value': '7', 'groupId': 'BG000'}, {'value': '5', 'groupId': 'BG001'}, {'value': '2', 'groupId': 'BG002'}, {'value': '0', 'groupId': 'BG003'}, {'value': '14', 'groupId': 'BG004'}]}, {'title': 'sdNVP+ZDV', 'measurements': [{'value': '33', 'groupId': 'BG000'}, {'value': '48', 'groupId': 'BG001'}, {'value': '6', 'groupId': 'BG002'}, {'value': '0', 'groupId': 'BG003'}, {'value': '87', 'groupId': 'BG004'}]}, {'title': 'sdNVP', 'measurements': [{'value': '41', 'groupId': 'BG000'}, {'value': '46', 'groupId': 'BG001'}, {'value': '15', 'groupId': 'BG002'}, {'value': '2', 'groupId': 'BG003'}, {'value': '104', 'groupId': 'BG004'}]}, {'title': 'One PI', 'measurements': [{'value': '0', 'groupId': 'BG000'}, {'value': '1', 'groupId': 'BG001'}, {'value': '0', 'groupId': 'BG002'}, {'value': '0', 'groupId': 'BG003'}, {'value': '1', 'groupId': 'BG004'}]}, {'title': 'One NRTI', 'measurements': [{'value': '2', 'groupId': 'BG000'}, {'value': '2', 'groupId': 'BG001'}, {'value': '0', 'groupId': 'BG002'}, {'value': '0', 'groupId': 'BG003'}, {'value': '4', 'groupId': 'BG004'}]}, {'title': 'No ARVs for prior PMTCT/no prior pregnancy', 'measurements': [{'value': '1456', 'groupId': 'BG000'}, {'value': '1442', 'groupId': 'BG001'}, {'value': '422', 'groupId': 'BG002'}, {'value': '202', 'groupId': 'BG003'}, {'value': '3522', 'groupId': 'BG004'}]}]}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'unitOfMeasure': 'Participants', 'populationDescription': 'Baseline ARV history data were incomplete for some participants.\n\nPI - Protease Inhibitor, NNRTI - Non Nucleoside Reverse Transcriptase Inhibitor, ZDV - Zidovudine, NVP - Nevirapine, NRTI - Nucleoside Reverse Transcriptase Inhibitor'}, {'title': 'The Last ARV Regimen before Entry during the Current Pregnancy', 'classes': [{'denoms': [{'units': 'Participants', 'counts': [{'value': '1539', 'groupId': 'BG000'}, {'value': '1544', 'groupId': 'BG001'}, {'value': '445', 'groupId': 'BG002'}, {'value': '204', 'groupId': 'BG003'}, {'value': '3732', 'groupId': 'BG004'}]}], 'categories': [{'title': 'HAART including NNRTI', 'measurements': [{'value': '1', 'groupId': 'BG000'}, {'value': '1', 'groupId': 'BG001'}, {'value': '0', 'groupId': 'BG002'}, {'value': '7', 'groupId': 'BG003'}, {'value': '9', 'groupId': 'BG004'}]}, {'title': 'Two NRTIs', 'measurements': [{'value': '2', 'groupId': 'BG000'}, {'value': '5', 'groupId': 'BG001'}, {'value': '3', 'groupId': 'BG002'}, {'value': '10', 'groupId': 'BG003'}, {'value': '20', 'groupId': 'BG004'}]}, {'title': 'sdNVP+ZDV', 'measurements': [{'value': '2', 'groupId': 'BG000'}, {'value': '0', 'groupId': 'BG001'}, {'value': '0', 'groupId': 'BG002'}, {'value': '1', 'groupId': 'BG003'}, {'value': '3', 'groupId': 'BG004'}]}, {'title': 'sdNVP', 'measurements': [{'value': '5', 'groupId': 'BG000'}, {'value': '2', 'groupId': 'BG001'}, {'value': '0', 'groupId': 'BG002'}, {'value': '33', 'groupId': 'BG003'}, {'value': '40', 'groupId': 'BG004'}]}, {'title': 'One NRTI', 'measurements': [{'value': '326', 'groupId': 'BG000'}, {'value': '336', 'groupId': 'BG001'}, {'value': '125', 'groupId': 'BG002'}, {'value': '0', 'groupId': 'BG003'}, {'value': '787', 'groupId': 'BG004'}]}, {'title': 'No ARVs during the current pregnancy', 'measurements': [{'value': '1203', 'groupId': 'BG000'}, {'value': '1200', 'groupId': 'BG001'}, {'value': '317', 'groupId': 'BG002'}, {'value': '153', 'groupId': 'BG003'}, {'value': '2873', 'groupId': 'BG004'}]}]}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'unitOfMeasure': 'Participants', 'populationDescription': 'Baseline ARV history data were incomplete for some participants.\n\nNNRTI - Non Nucleoside Reverse Transcriptase Inhibitor, NRTI - Nucleoside Reverse Transcriptase Inhibitor, NVP - Nevirapine, ZDV - Zidovudine'}], 'populationDescription': 'All women in 1077BF/1077FF except those considered ineligible for the analysis after team review.'}}, 'protocolSection': {'designModule': {'phases': ['PHASE3'], 'studyType': 'INTERVENTIONAL', 'designInfo': {'allocation': 'RANDOMIZED', 'maskingInfo': {'masking': 'DOUBLE', 'whoMasked': ['INVESTIGATOR', 'OUTCOMES_ASSESSOR'], 'maskingDescription': 'The investigators and outcomes assessor did not receive by-arm tabulations while the study was ongoing.'}, 'primaryPurpose': 'PREVENTION', 'interventionModel': 'PARALLEL'}, 'enrollmentInfo': {'type': 'ACTUAL', 'count': 3747}}, 'statusModule': {'overallStatus': 'COMPLETED', 'startDateStruct': {'date': '2011-03-01', 'type': 'ACTUAL'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2022-02', 'completionDateStruct': {'date': '2016-09-30', 'type': 'ACTUAL'}, 'lastUpdateSubmitDate': '2022-02-09', 'studyFirstSubmitDate': '2010-02-01', 'resultsFirstSubmitDate': '2017-09-28', 'studyFirstSubmitQcDate': '2010-02-01', 'lastUpdatePostDateStruct': {'date': '2022-02-11', 'type': 'ACTUAL'}, 'resultsFirstSubmitQcDate': '2018-01-12', 'studyFirstPostDateStruct': {'date': '2010-02-02', 'type': 'ESTIMATED'}, 'resultsFirstPostDateStruct': {'date': '2018-02-09', 'type': 'ACTUAL'}, 'primaryCompletionDateStruct': {'date': '2016-09-30', 'type': 'ACTUAL'}}, 'outcomesModule': {'otherOutcomes': [{'measure': 'Maternal Health Component: Cost-effectiveness', 'timeFrame': 'From study entry until July 7, 2015.', 'description': 'The protocol did not distinguish between outcomes essential to the primary publication and outcomes for subsequent publications of lesser priority. This outcome measure was listed as secondary in the protocol but the intention was as an exploratory outcome since cost-effectiveness was not a focus of the study.'}, {'measure': 'Maternal Health Component: Changes in Plasma Concentrations of Inflammatory and Thrombogenic Markers', 'timeFrame': 'From study entry until July 7, 2015.', 'description': 'The protocol did not distinguish between outcomes essential to the primary publication and outcomes for subsequent publications of lesser priority. This outcome measure was listed as secondary in the protocol but the intention was as an exploratory outcome since inflammation and thrombogenic markers were not a focus of the study.'}, {'measure': 'Maternal Health Component: Quality of Life', 'timeFrame': 'From study entry until July 7, 2015.', 'description': 'The protocol did not distinguish between outcomes essential to the primary publication and outcomes for subsequent publications of lesser priority. This outcome measure was listed as secondary in the protocol but the intention was as an exploratory outcome since quality of life was not a focus of the study.'}, {'measure': 'Maternal Health Component: Self-reported Adherence', 'timeFrame': 'From study entry until July 7, 2015.', 'description': 'The protocol did not distinguish between outcomes essential to the primary publication and outcomes for subsequent publications of lesser priority. This outcome measure was listed as secondary in the protocol but the intention was as an exploratory outcome since adherence was not a focus of the study.'}, {'measure': 'Maternal Health Component: Viral Resistance', 'timeFrame': 'From study entry until July 7, 2015.', 'description': 'The protocol did not distinguish between outcomes essential to the primary publication and outcomes for subsequent publications of lesser priority. This outcome measure was listed as secondary in the protocol but the intention was as an exploratory outcome since viral resistance was not a focus of the study.'}, {'measure': 'Postpartum Component: Functional Maternal Antibody and HIV-envelope Binding Responses in Breast Milk and Plasma, Until Cessation of Breastfeeding or 18 Months Postpartum, Whichever Comes First', 'timeFrame': 'Measured through the time of cessation of breastfeeding or 18 months postpartum, whichever comes first', 'description': 'The protocol did not distinguish between outcomes essential to the primary publication and outcomes for subsequent publications of lesser priority. This outcome measure was listed as secondary in the protocol but the intention was as an exploratory outcome since functional maternal antibody and HIV-envelope binding responses were not a focus of the study.'}, {'measure': 'Postpartum Component: Pharmacokinetic Parameters of ARV Drugs Measured in Maternal Plasma, Hair, Breast Milk, and Infant Blood (Plasma or Dried Blood Spot) Samples Collected at Birth; Weeks 1, 6, 14, and 26; and Subsequent Visits During Breastfeeding', 'timeFrame': 'Measured through the last study visit during breastfeeding, or 18 months postpartum, whichever comes first', 'description': 'The protocol did not distinguish between outcomes essential to the primary publication and outcomes for subsequent publications of lesser priority. This outcome measure was listed as secondary in the protocol but the intention was as an exploratory outcome since pharmacokinetics was not a focus of the study.'}, {'measure': 'Postpartum Component: Cost-effectiveness and Feasibility of the Study ARV Prophylaxis Regimens', 'timeFrame': 'Measured at the end of the 5-year study period', 'description': 'The protocol did not distinguish between outcomes essential to the primary publication and outcomes for subsequent publications of lesser priority. This outcome measure was listed as secondary in the protocol but the intention was as an exploratory outcome since cost-effectiveness was not a focus of the study.'}, {'measure': 'Postpartum Component: Rates and Patterns of Maternal and Infant Resistance to the Maternal and Infant ARV Regimens', 'timeFrame': 'Measured at the end of the 5-year study period', 'description': 'The protocol did not distinguish between outcomes essential to the primary publication and outcomes for subsequent publications of lesser priority. This outcome measure was listed as secondary in the protocol but the intention was as an exploratory outcome since viral resistance was not a focus of the study.'}, {'measure': 'Postpartum Component: Adherence to the Maternal and/or Infant ARV Regimens, as Measured by Maternal Report and Hair Measures', 'timeFrame': 'Week 6 visit (14 days - 9 weeks postpartum); Week 14 visit (10-19 weeks postpartum); Week 26 visit (20 to 31 weeks postpartum); Week 50 visit (44 to 55 weeks postpartum); and Week 74 visit (68 to 80 weeks postpartum).', 'description': 'Adherence is by maternal report; adherence through hair analysis is not included here.\n\nThe protocol did not distinguish between outcomes essential to the primary publication and outcomes for subsequent publications of lesser priority. This outcome measure was listed as secondary in the protocol but the intention was as an exploratory outcome since adherence was not a focus of the study.'}, {'measure': 'Antepartum Component: Antepartum Change in HBV DNA Viral Load Between Week 8 and Baseline Levels (Using Log HBV DNA) Among Women With Detectable HBV DNA Viral Loads at Baseline and Other HBV Outcome Measures', 'timeFrame': 'Measured at Week 8', 'description': 'The protocol did not distinguish between outcomes essential to the primary publication and outcomes for subsequent publications of lesser priority. This outcome measure was listed as secondary in the protocol but the intention was as an exploratory outcome measure since changes in HBV DNA Viral Load was not a focus of the study.'}, {'measure': 'Antepartum Component: Cost Effectiveness and Feasibility of the Trial ARV Regimens', 'timeFrame': 'Measured at the end of the 5-year study period', 'description': 'The protocol did not distinguish between outcomes essential to the primary publication and outcomes for subsequent publications of lesser priority. This outcome measure was listed as secondary in the protocol but the intention was as an exploratory outcome measure since cost effectiveness was not a focus of the study.'}, {'measure': 'Antepartum Component: Maternal and Infant Viral Resistance to the Maternal and Infant ARV Strategies', 'timeFrame': 'Measured at the end of the 5-year study period', 'description': 'The protocol did not distinguish between outcomes essential to the primary publication and outcomes for subsequent publications of lesser priority. This outcome measure was listed as secondary in the protocol but the intention was as an exploratory outcome measure since viral resistance was not a focus of the study.'}, {'measure': 'Antepartum Component: Adherence to the Maternal Antiretroviral (ARV) Regimen, as Measured by Maternal Report', 'timeFrame': 'Measured through the Week 1 postpartum study visit', 'description': 'The protocol did not distinguish between outcomes essential to the primary publication and outcomes for subsequent publications of lesser priority. This outcome measure was listed as secondary in the protocol but the intention was as an exploratory outcome measure since adherence was not a focus of the study.'}], 'primaryOutcomes': [{'measure': 'Antepartum Component: Number of Confirmed Infant HIV Infections', 'timeFrame': 'Measured at birth or Week 1 study visit', 'description': 'Defined as HIV nucleic acid test (NAT) positivity of the specimen drawn at either the birth (Day 0-5) or Week 1 (Day 6-14) visit, confirmed by HIV NAT positivity of a second specimen collected at a different time point'}, {'measure': 'Antepartum Component: Number of Mothers With Grade 3 or Higher Toxicities and Selected Grade 2 Hematologic, Renal, and Hepatic Adverse Events', 'timeFrame': 'Measured through the Week 1 postpartum study visit', 'description': 'These events were graded using the Division of AIDS (DAIDS) AE Grading Table, Version 1.0, December 2004, Clarification August 2009, which is available on the RSC website (http://rsc.tech-res.com).'}, {'measure': 'Antepartum Component: Number of Mothers With Obstetrical Complications', 'timeFrame': 'Measured through the Week 1 postpartum study visit', 'description': 'Complications included deaths, diagnoses, signs/symptoms, chemistry lab tests, or hematological lab tests, with grades of 3 (Severe) or worse. Obstetrical complications were those classified by the MedDra coding system as "Pregnancy, puerperium and perinatal conditions", except if the condition was the death of the fetus: "Abortions not specified as induced or spontaneous", "Abortions spontaneous", or "Stillbirth and foetal death."'}, {'measure': 'Antepartum Component: Number of Mothers With Adverse Pregnancy Outcomes (e.g.,Stillbirth, Preterm Delivery (< 37 Weeks), Low Birth Weight (< 2,500 Grams), and Congenital Anomalies)', 'timeFrame': 'Measured at birth', 'description': 'Composite outcome'}, {'measure': 'Postpartum Component: Incidence of Confirmed Infant HIV Infection', 'timeFrame': 'Measured through site recommended duration of breastfeeding, complete cessation of breastfeeding or 18 months of age, whichever comes first', 'description': 'Defined as infant HIV NAT positivity of a specimen drawn at any post-randomization visit (i.e., any visit after the Week 1 \\[Day 6-14\\] visit), confirmed by HIV NAT positivity of a second specimen drawn at a different time point. Analyses were conducted at the Mother-Infant (M-I) pair level, hence the worst outcome for multiple births was counted as a single event.'}, {'measure': 'Postpartum Component: Incidence of Grade 3 or Higher Adverse Events and Selected Grade 2 Hematologic, Renal, and Hepatic Adverse Events', 'timeFrame': 'Measured through site recommended duration of breastfeeding, complete cessation of breastfeeding or 18 months of age, whichever comes first', 'description': 'These events were graded using the Division of AIDS (DAIDS) AE Grading Table, Version 1.0, December 2004, Clarification August 2009, which is available on the RSC website (http://rsc.tech-res.com).'}, {'measure': 'Maternal Health Component: Incidence of Progression to AIDS-defining Illness or Death', 'timeFrame': 'From study entry until July 7, 2015, an average of 94 weeks of follow-up.', 'description': 'AIDS-defining illness refers to the WHO Clinical Stage 4 illnesses in Appendix IV of the protocol. These events were reviewed and confirmed by an Endpoint review group.'}], 'secondaryOutcomes': [{'measure': 'Antepartum Component: Number of Infant HIV Infections', 'timeFrame': 'Measured at the birth (<= 3 days postpartum) visit', 'description': 'Detected by HIV NAT positivity'}, {'measure': 'Antepartum Component: Probability of Overall and HIV-free Infant Survival Until 104 Weeks of Age, by Antepartum Arm (in Conjunction With Infants in the Postpartum Component)', 'timeFrame': 'Measured from birth through 104 weeks of age', 'description': 'For overall survival, failure was defined to be death. For HIV-free survival, failure was defined to be either death or developing HIV. The probability of living, or living without HIV infection, at 104 weeks was calculated by Kaplan-Meier estimation of the survival function.'}, {'measure': 'Antepartum Component: Maternal HIV RNA Less Than 400 Copies/mL at Delivery', 'timeFrame': 'Measured at the time of delivery', 'description': 'Analysis used the principle of intent to treat.'}, {'measure': 'Postpartum Component: Proportion of Mother-Infant Pairs With no Death or HIV Diagnosis Through 24 Months Post-delivery', 'timeFrame': 'Measured through 24 months post-delivery', 'description': 'Defined as infant HIV NAT positivity of a specimen drawn at any post-randomization visit, confirmed by HIV NAT positivity of a second specimen drawn at a different time point, or infant death. Analyses (Kaplan-Meier probabilities) were conducted at the Mother-Infant (M-I) pair level, hence the worst outcome for multiple births was counted as a single event.'}, {'measure': 'Postpartum Component: Proportion of Infants Alive Through 12 and 24 Months Post-delivery', 'timeFrame': 'Measured at 12 and 24 months post-delivery', 'description': 'Analyses (Kaplan-Meier probabilities) conducted for all individual infants (rather than M-I pair)'}, {'measure': 'Maternal Health Component: Incidence of Death', 'timeFrame': 'From study entry until July 7, 2015, an average of 94 weeks of follow-up.', 'description': 'Number of women who died during the maternal health component; that is, who had been randomized to either continue or discontinue ART after risk of HIV vertical transmission through breastfeeding was over.'}, {'measure': 'Maternal Health Component: Incidence of AIDS-defining Illness', 'timeFrame': 'From study entry until July 7, 2015, an average of 94 weeks of follow-up.', 'description': '"AIDS-defining illness" refers to the WHO Clinical Stage 4 illnesses listed in Appendix IV. Stage 4 illnesses were reviewed and confirmed by an Endpoint review group.'}, {'measure': 'Maternal Health Component: Incidence of HIV/AIDS-related Events', 'timeFrame': 'From study entry until July 7, 2015, an average of 94 weeks of follow-up.', 'description': '"HIV/AIDS-related event" refers to the WHO Clinical Stage 4 illnesses, pulmonary tuberculosis, and other serious bacterial infections listed in Appendix IV of the protocol. Stage 4 illnesses were reviewed and confirmed by an Endpoint review group.'}, {'measure': 'Maternal Health Component: Incidence Rate of Cardiovascular or Other Metabolic Events', 'timeFrame': 'From study entry until July 7, 2015, an average of 94 weeks of follow-up.', 'description': 'Cardiovascular or metabolic events of particular concern were included in this analysis. A Poisson model with time to first event as an offset and an over-dispersion parameter was used to estimate incidence rates.\n\nMetabolic events considered were diabetes mellitus, lipodystrophy, or dyslipidemia. Cardiovascular events considered were hypertension, congestive heart failure, stroke, Transient Ischemia Event (TIA), pulmonary embolism, myocardial infarction (whether acute symptomatic or silent), coronary artery disease, deep vein thrombosis, peripheral vascular disease, or symptomatic HIV-associated cardiomyopathy.'}, {'measure': 'Maternal Health Component: Other Targeted Medical Conditions', 'timeFrame': 'From study entry until July 7, 2015, an average of 94 weeks of follow-up.', 'description': 'Other (non-cardiologic) medical conditions of particular concern were included in this outcome. A Poisson model with time to first event as an offset and an over-dispersion parameter was used to estimate incidence rates. Events included were metabolic events, hepatic events, renal events, infections such as pulmonary tuberculosis, malaria, or other serious bacterial infections, and others.'}, {'measure': 'Maternal Health Component: Incidence of HIV/AIDS-related Event or Death', 'timeFrame': 'From study entry until July 7, 2015, an average of 94 weeks of follow-up.', 'description': '"HIV/AIDS-related event" refers to the WHO Clinical Stage 4 illnesses, pulmonary tuberculosis, and other serious bacterial infections listed in Appendix IV of the protocol. Stage 4 illnesses were reviewed and confirmed by an Endpoint review group.'}, {'measure': 'Maternal Health Component: Incidence of HIV/AIDS-related Event or World Health Organization (WHO) Clinical Stage 2 or 3 Events', 'timeFrame': 'From study entry until July 7, 2015, an average of 94 weeks of follow-up.', 'description': '"HIV/AIDS-related event" refers to the WHO Clinical Stage 4 illnesses, pulmonary tuberculosis, and other serious bacterial infections listed in Appendix IV of the protocol. Stage 4 illnesses were reviewed and confirmed by an Endpoint review group.'}, {'measure': 'Maternal Health Component: Incidence Rate of Death or Any Condition of Particular Concern', 'timeFrame': 'From study entry until July 7, 2015, an average of 94 weeks of follow-up.', 'description': 'Particular events were targeted as those of particular concern. This outcome considered all such events: death, events defining WHO stages II, III, or IV, targeted cardiovascular adverse events, other targeted adverse events, or cancers which were not AIDS-defining. A complete list can be found in Appendix IV of the Protocol. A Poisson model with time to first event as an offset and an over-dispersion parameter was used to estimate incidence rates.'}, {'measure': 'Maternal Health Component: Incidence of Tuberculosis', 'timeFrame': 'From study entry until July 7, 2015, an average of 94 weeks of follow-up.', 'description': 'Incidence of tuberculosis.'}, {'measure': 'Maternal Health Component: Toxicity: Incidence of Grade 3 or Greater Laboratory Results or Signs and Symptoms and Selected Grade 2 Hematologic, Renal, and Hepatic Laboratory Results', 'timeFrame': 'From study entry until July 7, 2015, an average of 94 weeks of follow-up.', 'description': 'The maternal safety endpoints summarized include grade 2, 3 or 4 hematologies (hemoglobin (Hb), White Blood Cells (WBC), Absolute Neutrophil Count (ANC), platelet count), chemistries (Alanine Aminotransferase (ALT or SGPT), serum creatinine), and grade 3 or 4 signs and symptoms that occurred post-randomization. These events were graded using the Division of AIDS (DAIDS) AE Grading Table, Version 1.0, December 2004, Clarification August 2009, which is available on the RSC website (http://rsc.tech-res.com).'}, {'measure': 'Maternal Health Component: Incidence Rate of Progression to AIDS-defining Illness, Death, or a Serious Non-AIDS Cardiovascular, Hepatic, or Renal Event', 'timeFrame': 'From study entry until July 7, 2015, an average of 94 weeks of follow-up.', 'description': 'This outcome included AIDS-defining illnesses or cardiovascular, hepatic, or renal adverse events of particular concern which were evaluated as serious. Serious outcomes were both those defined as serious according to the International Conference on Harmonization (ICH) definition, or outcomes with grades equal to or worse than 3 ("Severe"). A Poisson model with time to first event as an offset and an over-dispersion parameter was used to estimate incidence rates. Cardiovascular events considered were hypertension, congestive heart failure, stroke, Transient Ischemia Event (TIA), pulmonary embolism, myocardial infarction (whether acute symptomatic or silent), coronary artery disease, deep vein thrombosis, peripheral vascular disease, or symptomatic HIV-associated cardiomyopathy. Hepatic events considered were cirrhosis and idiopathic sclerosing cholangitis. Renal events considered were renal insufficiency, acute or chronic.'}]}, 'oversightModule': {'oversightHasDmc': True}, 'conditionsModule': {'keywords': ['Mother to Child Transmission', 'HIV Infection', 'HAART', 'Maternal Health', 'Breastfeeding', 'Perinatal transmission'], 'conditions': ['HIV Infections']}, 'referencesModule': {'references': [{'pmid': '20054287', 'type': 'BACKGROUND', 'citation': 'Taha T, Nour S, Li Q, Kumwenda N, Kafulafula G, Nkhoma C, Broadhead R. The effect of human immunodeficiency virus and breastfeeding on the nutritional status of African children. Pediatr Infect Dis J. 2010 Jun;29(6):514-8. doi: 10.1097/INF.0b013e3181cda531.'}, {'pmid': '19916796', 'type': 'BACKGROUND', 'citation': 'Becquet R, Ekouevi DK, Arrive E, Stringer JS, Meda N, Chaix ML, Treluyer JM, Leroy V, Rouzioux C, Blanche S, Dabis F. Universal antiretroviral therapy for pregnant and breast-feeding HIV-1-infected women: towards the elimination of mother-to-child transmission of HIV-1 in resource-limited settings. Clin Infect Dis. 2009 Dec 15;49(12):1936-45. doi: 10.1086/648446.'}, {'type': 'RESULT', 'citation': 'U.S. Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases, Division of AIDS. Division of AIDS Table for Grading the Severity of Adult and Pediatric Adverse Events, Version 1.0. [Updated August 2009]. Available from: http://rsc.tech-res.com/docs/default-source/safety/table_for_grading_severity_of_adult_pediatric_adverse_events.pdf'}, {'type': 'RESULT', 'citation': 'WHO Case Definitions of HIV for Surveillance and Revised Clinical Staging and Immunological Classification of HIV-related Disease in Adults and Children, World Health Organization, 2007. Available: http://apps.who.int/iris/handle/10665/43699'}, {'pmid': '37535953', 'type': 'DERIVED', 'citation': 'Bhattacharya D, Tierney C, Butler K, Kiweewa FM, Moodley D, Govender V, Vhembo T, Mohtashemi N, Ship H, Dula D, George K, Chaktoura N, Fowler MG, Peters MG, Currier JS. Comparison of Antiretroviral Therapies in Pregnant Women Living With Human Immunodeficiency Virus and Hepatitis B Virus: A Randomized Controlled Trial. Obstet Gynecol. 2023 Sep 1;142(3):613-624. doi: 10.1097/AOG.0000000000005302. Epub 2023 Aug 3.'}, {'pmid': '37199427', 'type': 'DERIVED', 'citation': 'Vhembo T, Baltrusaitis K, Tierney C, Owor M, Dadabhai S, Violari A, Theron G, Moodley D, Mukwasi-Kahari C, George K, Shepherd J, Siberry GK, Browning R, Fowler MG, Stranix-Chibanda L; IMPAACT P1084s study team. Bone and Renal Health in Infants With or Without Breastmilk Exposure to Tenofovir-Based Maternal Antiretroviral Treatment in the PROMISE Randomized Trial. J Acquir Immune Defic Syndr. 2023 Aug 15;93(5):431-437. doi: 10.1097/QAI.0000000000003218.'}, {'pmid': '36170749', 'type': 'DERIVED', 'citation': 'Nevrekar N, Butler K, Shapiro DE, Atuhaire P, Taha TE, Makanani B, Chinula L, Owor M, Moodley D, Chipato T, McCarthy K, Flynn PM, Currier J, Fowler MG, Gupta A, Suryavanshi N. Self-reported Antiretroviral Adherence: Association With Maternal Viral Load Suppression in Postpartum Women Living With HIV-1 From Promoting Maternal and Infant Survival Everywhere, a Randomized Controlled Trial in Sub-Saharan Africa and India. J Acquir Immune Defic Syndr. 2023 Jan 1;92(1):76-83. doi: 10.1097/QAI.0000000000003102. Epub 2022 Sep 28.'}, {'pmid': '35858874', 'type': 'DERIVED', 'citation': 'Baltrusaitis K, Makanani B, Tierney C, Fowler MG, Moodley D, Theron G, Nyakudya LH, Tomu M, Fairlie L, George K, Heckman B, Knowles K, Browning R, Siberry GK, Taha TE, Stranix-Chibanda L; PROMISE P1084s Study Team. Maternal and infant renal safety following tenofovir disoproxil fumarate exposure during pregnancy in a randomized control trial. BMC Infect Dis. 2022 Jul 20;22(1):634. doi: 10.1186/s12879-022-07608-8.'}, {'pmid': '34750297', 'type': 'DERIVED', 'citation': 'Fowler MG, Aizire J, Sikorskii A, Atuhaire P, Ogwang LW, Mutebe A, Katumbi C, Maliwichi L, Familiar I, Taha T, Boivin MJ; PROMISE-NEURODEV study team. Growth deficits in antiretroviral and HIV-exposed uninfected versus unexposed children in Malawi and Uganda persist through 60 months of age. AIDS. 2022 Mar 15;36(4):573-582. doi: 10.1097/QAD.0000000000003122.'}, {'pmid': '34415933', 'type': 'DERIVED', 'citation': 'Stranix-Chibanda L, Tierney C, Pinilla M, George K, Aizire J, Chipoka G, Mallewa M, Naidoo M, Nematadzira T, Kusakara B, Violari A, Mbengeranwa T, Njau B, Fairlie L, Theron G, Mubiana-Mbewe M, Khadse S, Browning R, Fowler MG, Siberry GK; PROMISE Study Team. Effect on growth of exposure to maternal antiretroviral therapy in breastmilk versus extended infant nevirapine prophylaxis among HIV-exposed perinatally uninfected infants in the PROMISE randomized trial. PLoS One. 2021 Aug 20;16(8):e0255250. doi: 10.1371/journal.pone.0255250. eCollection 2021.'}, {'pmid': '32564058', 'type': 'DERIVED', 'citation': 'Theron G, Brummel S, Fairlie L, Pinilla M, McCarthy K, Owor M, Chinula L, Makanani B, Violari A, Moodley D, Chakhtoura N, Browning R, Hoffman R, Fowler MG. Pregnancy Outcomes of Women Conceiving on Antiretroviral Therapy (ART) Compared to Those Commenced on ART During Pregnancy. Clin Infect Dis. 2021 Jul 15;73(2):e312-e320. doi: 10.1093/cid/ciaa805.'}, {'pmid': '31634154', 'type': 'DERIVED', 'citation': 'Aizire J, Sikorskii A, Ogwang LW, Kawalazira R, Mutebe A, Familiar-Lopez I, Mallewa M, Taha T, Boivin MJ, Fowler MG; PROMISE-NEURODEV study team. Decreased growth among antiretroviral drug and HIV-exposed uninfected versus unexposed children in Malawi and Uganda. AIDS. 2020 Feb 1;34(2):215-225. doi: 10.1097/QAD.0000000000002405.'}, {'pmid': '30890061', 'type': 'DERIVED', 'citation': 'Hoffman RM, Angelidou KN, Brummel SS, Saidi F, Violari A, Dula D, Mave V, Fairlie L, Theron G, Kamateeka M, Chipato T, Chi BH, Stranix-Chibanda L, Nematadzira T, Moodley D, Bhattacharya D, Gupta A, Coletti A, McIntyre JA, Klingman KL, Chakhtoura N, Shapiro DE, Fowler MG, Currier JS; IMPAACT PROMISE 1077BF/FF team. Maternal health outcomes among HIV-infected breastfeeding women with high CD4 counts: results of a treatment strategy trial. HIV Clin Trials. 2018 Dec;19(6):209-224. doi: 10.1080/15284336.2018.1537327.'}, {'pmid': '27806243', 'type': 'DERIVED', 'citation': 'Fowler MG, Qin M, Fiscus SA, Currier JS, Flynn PM, Chipato T, McIntyre J, Gnanashanmugam D, Siberry GK, Coletti AS, Taha TE, Klingman KL, Martinson FE, Owor M, Violari A, Moodley D, Theron GB, Bhosale R, Bobat R, Chi BH, Strehlau R, Mlay P, Loftis AJ, Browning R, Fenton T, Purdue L, Basar M, Shapiro DE, Mofenson LM; IMPAACT 1077BF/1077FF PROMISE Study Team. Benefits and Risks of Antiretroviral Therapy for Perinatal HIV Prevention. N Engl J Med. 2016 Nov 3;375(18):1726-1737. doi: 10.1056/NEJMoa1511691.'}], 'seeAlsoLinks': [{'url': 'http://www.impaactnetwork.org/studies/1077BF.asp', 'label': 'IMPAACT Study 1077BF'}, {'url': 'https://www.meddra.org/', 'label': 'MedDra coding of complications'}]}, 'descriptionModule': {'briefSummary': 'The purpose of this study was to examine, in an integrated and comprehensive fashion, three critical questions currently facing HIV-infected pregnant and postpartum women and their infants:\n\n1. What is the optimal intervention for the prevention of antepartum and intrapartum transmission of HIV?\n2. What is the optimal intervention for the prevention of postpartum transmission in breastfeeding (BF) infants?\n3. What is the optimal intervention for the preservation of maternal health after the risk period for prevention of mother-to-child-transmission ends (either at delivery or cessation of BF)?\n\nThe overall PROMISE protocol had three separate interventional components to address each of these three questions and was conducted at locations in Africa and other parts of the world. Due to variations in the standard of care for HIV-infected pregnant and postpartum women and their infants at different sites, not all of these questions were relevant. Therefore, two separate versions of the PROMISE protocol were developed, each containing only the relevant components. The 1077BF protocol was used at sites where the standard method of infant feeding was breastfeeding, whereas the 1077FF protocol was used at sites where the standard method of infant feeding was formula feeding. The analyses were collapsed across the two protocol versions, and therefore the summaries contain the results of the 1077BF and/or the 1077FF protocols.', 'detailedDescription': "The incidence of mother-to-child transmission (MTCT) of HIV has decreased in recent years in the United States, Europe, and other resource-advantaged countries. Several factors have contributed to this decrease, including the administration of HAART during pregnancy, caesarean section delivery methods, and the use of formula instead of breastfeeding to feed infants. However, in resource-limited countries, the incidence of pediatric HIV infection remains high. Many pregnant women in these countries do not receive an adequate course of HAART, and the majority breastfeed their children.\n\nThis study was divided into three components (Antepartum, Postpartum, and Maternal Health Components). The following is a description of each of the three open label sequential randomization components, each designed to address one of the following three main objectives:\n\n1. Antepartum Component: This PROMISE component compared the safety and efficacy of different HAART regimens for preventing the transmission of HIV during pregnancy, labor, and delivery.\n\n * Participants were randomly assigned to one of the following three arms:\n * Maternal Regimens:\n\n * Arm A : 1) Zidovudine (ZDV) from study entry through delivery, 2) single dose nevirapine (sdNVP) and emtricitabine-tenofovir disoproxil (TRV ) intrapartum, and 3) TRV postpartum for up to 14 days post-partum. Arm A is also labeled as ZDV+sdNVP+TRV tail.\n * Arm B: Lamivudine (3TC)-zidovudine (ZDV) + lopinavir (LPV)-ritonavir (RTV) from study entry up to 14 days postpartum. Arm B is also labeled as 3TC-ZDV/LPV-RTV.\n * Arm C: TRV/LPV-RTV from study entry up to 14 days postpartum. Arm C is also labeled as FTC-TDF/LPV-RTV.\n * All infants born to women enrolled in this study were to receive NVP once a day as soon as possible after birth through 42 days of age or until the Week 6 study visit, whichever was later. Women switched or initiated HAART if it was needed for their own health.\n * During pregnancy, participants attended study visits at study entry, 2 and 4 weeks after entry, and then every 4 weeks until labor and delivery. Women and infants were monitored during labor and delivery and attended a study visit 6 to 14 days after delivery. After delivery, eligibility criteria were assessed for subsequent randomizations (either Postpartum or Maternal Health). If they failed the entry criteria for the subsequent randomization, the mothers remained in follow-up for safety assessments and the infants were followed until the 104 week visit; otherwise they were followed under the subsequent component.\n * All three antepartum arms were not available to all women throughout the PROMISE study. When the trial began, there were limited safety data on tenofovir in pregnancy, and randomization to tenofovir-based ART was limited to women coinfected with HIV and HBV, because benefit was felt to outweigh risk in that group. During period 1 (PROMISE protocol version 2.0 - April 2011 through September 2012), women without HBV coinfection were randomized to either Arm A or Arm B; and Hepatitis B (HBV) co-infected women were randomized to either Arm A, Arm B, or Arm C. However, in October 2012, with increased data on tenofovir in pregnancy, the protocol was modified to allow women regardless of HBV status to be assigned to any of the three regimens during period 2 (PROMISE protocol version 3.0 - October 2012 through the end of antepartum enrollment on October 1, 2014). By arm comparisons were restricted to times in which there were contemporaneous randomizations.\n * Late Presenters: In addition the Antepartum Component, participants could enter PROMISE through the Late Presenters Registration (LP). Late presenters were identified in early or active labor or in the immediate postpartum period (up to 5 days postpartum). The Late Presenters Registration facilitated a structure to screen women and infants for randomization in the Postpartum Component. Women and infants not randomized in the Postpartum Component of PROMISE were followed through the Week 6 visit.\n * There were 3543 mothers and 3407 live born infants enrolled in the Antepartum Component. There were 204 mothers and 204 live born infants in the Late Presenters Registration.\n2. Postpartum Component: This PROMISE component compared the safety and efficacy of maternal triple ARV prophylaxis versus daily infant NVP prophylaxis for the prevention of mother-to-child transmission (PMTCT) through breastfeeding. The Postpartum Component consisted of mothers and infants from the Antepartum Component and the Late Presenters Registration who passed the Postpartum Component entry criteria.\n\n * Participants were randomly assigned to one of two arms:\n\n * Arm A: Women received LPV-RTV plus TRV from the Week 1 postpartum visit through the end of maternal follow-up (2 to 5 years). Infants received NVP once a day through 42 days of age or until the Week 6 study visit, whichever was later.\n * Arm B: Infants received NVP once a day from the Week 1 postpartum visit until the end of risk for MTCT or until 18 months postpartum (104 weeks). Women did not receive antiretroviral drugs for MTCT prophylaxis.\n * The maternal study visits were at entry, at postpartum weeks 6, 14, 26, and every 12 weeks thereafter. Infant study visits were at entry, every 4 weeks between postpartum weeks 6-26, every 12 weeks between postpartum week 38-98, and at postpartum week 104. At the end of risk for MTCT or 18 months postpartum, the mothers' eligibility criteria were assessed for a subsequent randomization in the Maternal Health Component. If they did not meet entry criteria for the Maternal Health randomization, they remained in follow-up for safety assessments; otherwise they were followed under the Maternal Health Component. Infants were followed until the 104 week visit.\n * Women switched or initiated HAART if it was needed for their own health. If a woman in Arm B initiated HAART then her infant discontinued NVP after 12 weeks of HAART or after her viral load was suppressed, whichever came first.\n * There were 2431 mothers and 2444 infants randomized as part of the Postpartum Component.\n3. Maternal Health Component: This PROMISE component randomized women to continue or discontinue HAART after the end of risk for MTCT, either after delivery or after breastfeeding. Participants included women who were receiving the triple ARV regimen in the Postpartum Component; or receiving the triple ARV regimen in the Antepartum Component and were ineligible for the Postpartum Component.\n\n * Participants were randomly assigned to one of two study arms:\n\n * Arm A: Participants continued to receive the triple ARV regimen (preferred regimen was LPV-RTV plus TRV).\n * Arm B: Participants discontinued the triple ARV regimen.\n * Study visits occurred at Weeks 4 and 12 and then every 3 months thereafter. Study visits included a medical history review, questionnaires, physical exam, and blood collection. Women switched or initiated a triple ARV regimen if it was needed for their own health.\n * There were 875 mothers randomized as part of the Maternal Health Component.\n * The analyses for the Maternal Health Component we not solely based on the Maternal Health Randomization. Instead there were four prespecified comparison groups for the Maternal Health Component. The four comparison groups used the three randomizations as appropriate to answer the following questions:\n\n * Question 1: What is the effect on women of using a maternal triple ARV regimen to prevent MTCT during pregnancy, relative to using ZDV + sdNVP + TRV tail to prevent MTCT during pregnancy?\n * Question 2: What is the effect on women of using a maternal triple ARV regimen to prevent MTCT during breastfeeding, relative to using infant NVP to prevent MTCT during breastfeeding?\n * Question 3: What is the effect on women of extending versus discontinuing the antepartum/intrapartum maternal triple ARV regimen at the time of birth?\n * Question 4: What is the effect on women of extending versus discontinuing the postpartum maternal triple ARV regimen after the cessation of risk for MTCT during breastfeeding?\n * There were 1602 mothers included in the analyses for Question 2.\n\nPROMISE mothers were followed for 2 to 5 years, depending on when they enrolled. Infants were followed up to 104 weeks of age. Infant and maternal follow-up ended in September 2016. PROMISE randomizations were halted in the summer of 2014 due to slow accrual to the Later Presenters Registration and the Formula Feeding protocol. Due to the results of an external study, on July 7th 2015 the PROMISE interventions were halted and ART was offered to all participants. Per recommendation from the Data and Safety and Monitoring Board on November 4th 2014, the primary analyses for the Antepartum Component include follow-up through September 10th, 2014. Per recommendation from the Data and Safety and Monitoring Board on November 12th 2015, the primary analyses for the Postpartum Component include follow-up through July 7th, 2015. The Adverse Events in the Reported Adverse Event section include all study follow-up."}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['CHILD', 'ADULT', 'OLDER_ADULT'], 'healthyVolunteers': False, 'eligibilityCriteria': 'Antepartum Component Inclusion Criteria:\n\n* Confirmed HIV-1 infection, defined as documented positive results from two samples collected at different time points prior to study entry. More information on this criterion can be found in the protocol.\n* Currently pregnant and greater than or equal to 14 weeks gestation based on clinical or other obstetrical measurements\n* CD4 count greater than or equal to 350 cells/mm\\^3, or greater than or equal to the country-specific threshold for initiation of treatment (if that threshold is greater than 350 cells/mm\\^3), on a specimen obtained within 30 days prior to study entry\n* Results of HBV screening (HBsAg testing) available from specimen obtained within 30 days prior to study entry\n* The following laboratory values from a specimen obtained within 30 days prior to study entry:\n\n 1. Hemoglobin greater than or equal to 7.5 g/dL\n 2. White blood cell count (WBC) greater than or equal to 1,500 cells/mm\\^3\n 3. Absolute neutrophil count (ANC) greater than or equal to 750 cells/mm\\^3\n 4. Platelets greater than or equal to 50,000 cells/mm\\^3\n 5. Alanine aminotransferase (ALT) less than or equal to 2.5 times the upper limit of normal (ULN)\n 6. Estimated creatinine clearance of greater than or equal to 60 mL/min using the Cockroft-Gault equation for women\n* Plans to deliver in the study-affiliated clinic or hospital\n* Has no plans to move outside of the study site area during the 24 months following delivery\n* Age of legal majority for the respective country and willing and able to provide written informed consent\n\nAntepartum Component Exclusion Criteria:\n\n* Participation in PROMISE for a prior pregnancy\n* Ingestion of any antiretroviral (ARV) regimen with three or more drugs (regardless of duration) or more than 30 days of a single or dual ARV regimen during current pregnancy, according to self report or available medical records\n* Requires triple ARV therapy (HAART) for own health based on local standard guidelines\n* World Health Organization (WHO) stage 4 disease\n* Prior receipt of HAART for maternal treatment indications (e.g., CD4 less than 350 cells/mm\\^3 or clinical indications); however, could have received ARVs for the sole purpose of prevention of mother-to-child transmission (PMTCT) in previous pregnancies (prior PMTCT regimens could have included a triple ARV regimen, ZDV, 3TC-ZDV, and/or sdNVP for PMTCT, as well as use of a short dual nucleoside reverse transcriptase inhibitor \\[NRTI\\] "tail" to reduce risk of NVP resistance.)\n* In labor - at onset or beyond (may be eligible for the Late Presenter registration)\n* Clinically significant illness or condition requiring systemic treatment and/or hospitalization within 30 days prior to study entry\n* Current or history of tuberculosis (TB) disease (positive PPD without TB disease is not exclusionary)\n* Use of prohibited medications within 14 days prior to study entry (refer to the protocol for a list of prohibited medications)\n* Fetus detected to have serious congenital malformation (ultrasound not required to rule out this condition)\n* Current documented conduction heart defect (specialized assessments to rule out this condition are not required; a heart murmur alone and/or type 1 second-degree atrioventricular block \\[also known as Mobitz I or Wenckebach\\] is not considered exclusionary)\n* Known to meet the local standard criteria for treatment of HBV (Note: HBV DNA testing or other specialized assessments are not expected to be performed as part of this study. A woman would be excluded only if this information is documented from other sources and she meets the local standard criteria for HBV treatment based on those assessments.)\n* Social or other circumstances that would hinder long-term follow-up, in the opinion of the site investigator\n* Currently incarcerated\n\nLate Presenter Inclusion Criteria:\n\n* Age of legal majority for the respective country\n* HIV-1 infection, defined as documented positive results from tests performed on one sample at any time prior to Late Presenter Registration\n* In labor (from onset/early labor or beyond) or within 5 days after delivery (with day of delivery considered day 0)\n* Has provided written informed consent\n* Has no plans to move outside of the study site area during the 24 months following delivery\n* If delivered, infant alive and healthy (In the case of a multiple birth, a mother-infant pair will be included in the Late Presenter registration only if both/all infants and the mother meet the eligibility criteria. If only one infant of a multiple birth is alive, the M-I pair may be registered if the infant and the mother otherwise meet all of the eligibility criteria.)\n\nLate Presenter Exclusion Criteria:\n\n* Participation in PROMISE in prior pregnancy\n* Ingestion of any antiretroviral regimen during current pregnancy (including for solely for PMTCT), according to self report and available medical records (Note: Use of ARVs provided as standard of care for PMTCT during labor/delivery or postpartum prior to Late Presenter registration is not exclusionary.)\n* If known: CD4 count \\< 350 cells/mm3 or below the country-specific threshold for initiation of treatment, if that threshold is \\> 350 cells/mm3, on specimen obtained within 30 days prior to study entry (result not required prior to registration)\n* Requires triple ARV therapy (HAART) for own health according to local standard guidelines\n* WHO Stage 4 disease\n* Prior receipt of HAART for maternal treatment indications (e.g., CD4 \\< 350 cells/mm3 or clinical indications); however, could have received ARVs for the sole purpose of PMTCT in previous pregnancies. (Prior PMTCT regimens could have included a triple ARV regimen, ZDV, 3TCZDV and/or sdNVP for PMTCT, as well as use of a short dual NRTI "tail" to reduce risk of NVP resistance.)\n* Current or history of TB disease (positive PPD without TB disease is not exclusionary)\n* Known positive infant HIV nucleic acid test (NAT) result (result not required prior to registration)\n* Fetal demise or early neonatal death (prior to enrollment/registration)\n* Fetus detected with serious congenital malformation (ultrasound not required to rule out this condition)\n* Life threatening infant illness or birth condition incompatible with life\n* If delivered, infant birth weight \\< 2.0 kg\n* Social or other circumstances which would hinder long-term follow-up, in the opinion of the site investigator\n* Current documented conduction heart defect (specialized assessments to rule out this condition are not required; a heart murmur alone and/or type 1 second-degree atrioventricular block (also known as Mobitz I or Wenckebach) is not considered exclusionary)\n\nPostpartum Component Inclusion Criteria:\n\n* Participation in the Antepartum Component or registered as a Late Presenter\n* Provided written informed consent\n* Has no plans to move outside of the study site area during the 24 months following delivery\n* Maternal CD4 count greater than or equal to 350 cells/mm\\^3, or greater than or equal to the country-specific threshold for initiation of treatment (if that threshold is greater than 350 cells/mm\\^3), from a specimen obtained within 30 days prior to study entry. More information on this criterion can be found in the protocol.\n* The following maternal laboratory values within 30 days prior to entry:\n\n 1. Hemoglobin greater than or equal to 7.0 g/dL\n 2. WBC greater than or equal to 1,500 cells/mm\\^3\n 3. ANC greater than or equal to 750 cells/mm\\^3\n 4. Platelets greater than or equal to 50,000 cells/mm\\^3\n 5. ALT less than or equal to 2.5 times the upper limit of normal (ULN)\n 6. Estimated creatinine clearance of greater than or equal to 60 mL/min using the Cockroft-Gault equation for women\n* Infant alive, healthy, less than or equal to 14 days of age, and uninfected (negative HIV NAT result on specimen drawn prior to study entry)\n* The following infant lab values on specimen obtained prior to study entry (within 14 days of birth):\n\n 1. Hemoglobin greater than or equal to 10 g/dL\n 2. WBC greater than or equal to 1,500 cells/mm\\^3\n 3. ANC greater than or equal to 750 cells/mm\\^3\n 4. Platelets greater than or equal to 50,000 cells/mm\\^3\n 5. ALT less than or equal to 2.5 times the ULN\n* For Registered Late Presenters: Confirmed maternal HIV-1 infection, defined as documented positive results from two samples collected at different time points at any time prior to entry. More information on this criterion can be found in the protocol.\n\nPostpartum Component Exclusion Criteria:\n\n* Positive infant HIV NAT result on specimen drawn prior to entry or no infant HIV NAT result on specimen drawn prior to entry\n* Life-threatening infant illness or birth condition incompatible with life\n* Infant birth weight less than 2.0 kg\n* Social or other circumstances that would hinder long-term follow-up, as judged by the site investigator\n* Current or history of TB disease (positive PPD without TB disease is not exclusionary)\n* Current documented conduction heart defect (specialized assessments to rule out this condition are not required; a heart murmur alone and/or type 1 second-degree atrioventricular block \\[also known as Mobitz I or Wenckebach\\] is not considered exclusionary)\n* Requires triple ARV therapy (HAART) for own health\n\nMaternal Health Component Inclusion Criteria:\n\n* Randomly assigned to triple ARV prophylaxis as part of the Postpartum Component and has continued triple ARV prophylaxis until the current randomization without treatment interruption (defined as more than 14 consecutive days of missed dosing) within the previous 30 days; OR randomly assigned to triple ARV prophylaxis in the Antepartum Component but ineligible for the Postpartum Component and has continued triple ARV prophylaxis until the current randomization without treatment interruption (defined as more than 7 consecutive days of missed dosing) within the previous 30 days\n* Within two weeks after complete breastfeeding cessation is achieved (defined as completely stopping all exposure to breast milk for greater than or equal to 28 days); i.e., within 29 to 42 days of last breast milk exposure, or reached 18 months postpartum (whichever comes first). Women who reach 18 months postpartum while still breastfeeding will be eligible for entry within 2 weeks before and 4 weeks after the Week 74 visit (Week 72-78); OR if the woman was randomized to triple ARV prophylaxis in the Postpartum Component and her infant is infected and still breastfeeding, she will be eligible for the Maternal Health Component within 42 days of specimen collection for the confirmatory infant HIV NAT; OR if the woman was randomized to triple ARV prophylaxis in the Antepartum Component but mother-infant pair was ineligible for the Postpartum Component she will be eligible for the Maternal Health Component beginning at the Week 1 visit (6-14 days postpartum) through 28 days after delivery; these women should be randomized as soon as possible, ideally within 6-14 days after delivery; OR if the woman was randomized to triple ARV prophylaxis in the Postpartum Component and breastfeeding risk for MTCT ceases for other reasons (e.g., infant death or permanent removal from home through legal services or adoption) within 28 days of event. More information on this criterion can be found in the protocol.\n* Provided written informed consent\n* CD4 cell count greater than or equal to 350 cells/mm\\^3, or greater than or equal to the country-specific threshold for initiation of treatment (if that threshold is greater than 350 cells/mm\\^3), on a specimen obtained within 30 days prior to study entry\n* The following laboratory values on a specimen obtained within 30 days prior to study entry:\n\n 1. ANC greater than or equal to 750 cells/mm\\^3\n 2. Hemoglobin greater than or equal to 7.0 gm/dL\n 3. Platelet count greater than or equal to 50,000 cells/mm\\^3\n 4. ALT (SGPT) less than or equal to 2.5 times the ULN\n 5. Estimated creatinine clearance of greater than or equal to 60 mL/min using the Cockroft-Gault equation for women\n* Intend to remain in current geographical area of residence for the duration of study\n\nMaternal Health Component Exclusion Criteria:\n\n* WHO Stage 4 disease\n* Clinically significant illness or condition requiring systemic treatment and/or hospitalization within 30 days prior to study entry\n* Current or history of TB disease (positive PPD without TB disease is not exclusionary)\n* Use of prohibited medications within 14 days prior to study entry\n* Social or other circumstances that would hinder long term follow-up as judged by the site investigator\n* Current documented conduction heart defect (specialized assessments to rule out this condition are not required; a heart murmur alone and/or type 1 second-degree atrioventricular block \\[also known as Mobitz I or Wenckebach\\] is not considered exclusionary)\n* Requires a triple ARV regimen for own health'}, 'identificationModule': {'nctId': 'NCT01061151', 'acronym': 'PROMISE', 'briefTitle': 'Evaluating Strategies to Reduce Mother-to-Child Transmission of HIV Infection in Resource-Limited Countries', 'nctIdAliases': ['NCT01253538'], 'organization': {'class': 'NIH', 'fullName': 'National Institute of Allergy and Infectious Diseases (NIAID)'}, 'officialTitle': 'Breastfeeding Version of the PROMISE Study (Promoting Maternal and Infant Survival Everywhere)', 'orgStudyIdInfo': {'id': '1077BF (PROMISE)'}, 'secondaryIdInfos': [{'id': '10777', 'type': 'REGISTRY', 'domain': 'DAIDS ES'}, {'id': 'IMPAACT 1077BF'}]}, 'armsInterventionsModule': {'armGroups': [{'type': 'ACTIVE_COMPARATOR', 'label': 'Antepartum Arm A', 'description': 'Mothers received ZDV + sdNVP + TRV Tail', 'interventionNames': ['Drug: Zidovudine (ZDV)', 'Drug: Nevirapine (NVP): Antepartum Mothers', 'Drug: Emtricitabine-tenofovir disoproxil fumarate (Truvada [TRV]) tail', 'Drug: Nevirapine (NVP): Infant short-course']}, {'type': 'EXPERIMENTAL', 'label': 'Antepartum Arm B', 'description': 'Mothers received Triple ARV (3TC-ZDV + LPV-RTV)', 'interventionNames': ['Drug: Lamivudine-Zidovudine (3TC-ZDV)', 'Drug: Lopinavir-ritonavir (LPV-RTV)', 'Drug: Nevirapine (NVP): Infant short-course']}, {'type': 'EXPERIMENTAL', 'label': 'Antepartum Arm C', 'description': 'Mothers received Triple ARV (TRV + LPV-RTV)', 'interventionNames': ['Drug: Lopinavir-ritonavir (LPV-RTV)', 'Drug: Emtricitabine-tenofovir disoproxil fumarate (Truvada [TRV])', 'Drug: Nevirapine (NVP): Infant short-course']}, {'type': 'OTHER', 'label': 'Late Presenters', 'description': 'Registration to facilitate a structure to screen women and infants for randomization in the Postpartum Component.', 'interventionNames': ['Other: No Intervention']}, {'type': 'EXPERIMENTAL', 'label': 'Postpartum Arm A (Maternal Prophylaxis)', 'description': 'Mothers received prophylaxis \\[preferred regimen: TRV + LPV-RTV\\]. Infants received short-course NVP.', 'interventionNames': ['Drug: Lopinavir-ritonavir (LPV-RTV)', 'Drug: Emtricitabine-tenofovir disoproxil fumarate (Truvada [TRV])', 'Drug: Nevirapine (NVP): Infant short-course']}, {'type': 'EXPERIMENTAL', 'label': 'Postpartum Arm B (Infant Prophylaxis)', 'description': 'Infants received extended NVP.', 'interventionNames': ['Drug: Nevirapine (NVP): Infant extended']}, {'type': 'EXPERIMENTAL', 'label': 'Maternal Health Arm A (Continue triple ARVs)', 'description': 'Mothers continued receiving triple ARV regimen \\[preferred regimen: TRV + LPV-RTV\\].', 'interventionNames': ['Other: Continue triple ARVs']}, {'type': 'ACTIVE_COMPARATOR', 'label': 'Maternal Health Arm B (Discontinue triple ARVs)', 'description': 'Mothers discontinued triple ARV regimen.', 'interventionNames': ['Other: Discontinue triple ARVs']}], 'interventions': [{'name': 'Zidovudine (ZDV)', 'type': 'DRUG', 'description': '300 mg twice daily', 'armGroupLabels': ['Antepartum Arm A']}, {'name': 'Nevirapine (NVP): Antepartum Mothers', 'type': 'DRUG', 'description': '200 mg at onset of labor', 'armGroupLabels': ['Antepartum Arm A']}, {'name': 'Emtricitabine-tenofovir disoproxil fumarate (Truvada [TRV]) tail', 'type': 'DRUG', 'description': '200 mg/300 mg x 2 tablets at onset of labor or as soon as possible thereafter; 200 mg/300 mg orally each day after delivery for 7 days or the date of the Week 1 visit (up to 14 days), whichever is later.', 'armGroupLabels': ['Antepartum Arm A']}, {'name': 'Lamivudine-Zidovudine (3TC-ZDV)', 'type': 'DRUG', 'description': '150 mg/300 mg twice daily', 'armGroupLabels': ['Antepartum Arm B']}, {'name': 'Lopinavir-ritonavir (LPV-RTV)', 'type': 'DRUG', 'description': '400 mg/100 mg twice daily beginning at \\>= 14 weeks gestation; 600 mg/150 mg twice daily beginning at \\>= 28 weeks gestation or at next visit (during third trimester) through delivery; 400 mg/100 mg twice daily after delivery up to 14 days postpartum.', 'armGroupLabels': ['Antepartum Arm B', 'Antepartum Arm C', 'Postpartum Arm A (Maternal Prophylaxis)']}, {'name': 'Emtricitabine-tenofovir disoproxil fumarate (Truvada [TRV])', 'type': 'DRUG', 'description': '200 mg/300 mg', 'armGroupLabels': ['Antepartum Arm C', 'Postpartum Arm A (Maternal Prophylaxis)']}, {'name': 'Nevirapine (NVP): Infant short-course', 'type': 'DRUG', 'description': 'Oral suspension (dosing according to birth weight) once a day through 42 days of age or through the week 6 visit, whichever is later.', 'armGroupLabels': ['Antepartum Arm A', 'Antepartum Arm B', 'Antepartum Arm C', 'Postpartum Arm A (Maternal Prophylaxis)']}, {'name': 'Nevirapine (NVP): Infant extended', 'type': 'DRUG', 'description': 'Oral suspension (dosing according to birth weight) once a day from 6 (up to 14) days of age until there was no longer any risk of MTCT or until the end of follow-up (104 weeks), whichever came first.', 'armGroupLabels': ['Postpartum Arm B (Infant Prophylaxis)']}, {'name': 'No Intervention', 'type': 'OTHER', 'description': 'Women registered before/during labor received the full Antepartum Arm A regimen.\n\nWomen registered after labor, and who received nevirapine outside of the study, received the Emtricitabine-tenofovir disoproxil fumarate (Truvada \\[TRV\\]) tail.', 'armGroupLabels': ['Late Presenters']}, {'name': 'Discontinue triple ARVs', 'type': 'OTHER', 'description': 'ARVs were discontinued. When protocol specified criteria were met, mothers could be prescribed any licensed antiretroviral medication, as long as the treatment met the definition of HAART (three ARV drugs from two or more drug classes).', 'armGroupLabels': ['Maternal Health Arm B (Discontinue triple ARVs)']}, {'name': 'Continue triple ARVs', 'type': 'OTHER', 'description': 'Mothers could be prescribed any licensed antiretroviral medication, as long as the treatment met the definition of HAART (three ARV drugs from two or more drug classes).', 'armGroupLabels': ['Maternal Health Arm A (Continue triple ARVs)']}]}, 'contactsLocationsModule': {'locations': [{'zip': '411001', 'city': 'Pune', 'state': 'Maharashtra', 'country': 'India', 'facility': 'Byramjee Jeejeebhoy Medical College (BJMC) CRS', 'geoPoint': {'lat': 18.51957, 'lon': 73.85535}}, {'city': 'Blantyre', 'country': 'Malawi', 'facility': 'Blantyre CRS', 'geoPoint': {'lat': -15.78499, 'lon': 35.00854}}, {'city': 'Lilongwe', 'country': 'Malawi', 'facility': 'Malawi CRS', 'geoPoint': {'lat': -13.96692, 'lon': 33.78725}}, {'zip': '1862', 'city': 'Johannesburg', 'state': 'Gauteng', 'country': 'South Africa', 'facility': 'Soweto IMPAACT CRS', 'geoPoint': {'lat': -26.20227, 'lon': 28.04363}}, {'zip': '2001', 'city': 'Johannesburg', 'state': 'Gauteng', 'country': 'South Africa', 'facility': 'Shandukani Research CRS', 'geoPoint': {'lat': -26.20227, 'lon': 28.04363}}, {'zip': '4001', 'city': 'Durban', 'state': 'KwaZulu-Natal', 'country': 'South Africa', 'facility': 'Durban Paediatric HIV CRS', 'geoPoint': {'lat': -29.8579, 'lon': 31.0292}}, {'zip': '4001', 'city': 'Durban', 'state': 'KwaZulu-Natal', 'country': 'South Africa', 'facility': 'Umlazi CRS', 'geoPoint': {'lat': -29.8579, 'lon': 31.0292}}, {'zip': '7505', 'city': 'Cape Town', 'state': 'Western Cape', 'country': 'South Africa', 'facility': 'Family Clinical Research Unit (FAM-CRU) CRS', 'geoPoint': {'lat': -33.92584, 'lon': 18.42322}}, {'city': 'Moshi', 'country': 'Tanzania', 'facility': 'Kilimanjaro Christian Medical Centre (KCMC)', 'geoPoint': {'lat': -3.35, 'lon': 37.33333}}, {'city': 'Kampala', 'country': 'Uganda', 'facility': 'MU-JHU Research Collaboration (MUJHU CARE LTD) CRS', 'geoPoint': {'lat': 0.31628, 'lon': 32.58219}}, {'city': 'Lusaka', 'country': 'Zambia', 'facility': 'George CRS', 'geoPoint': {'lat': -15.40669, 'lon': 28.28713}}, {'city': 'Chitungwiza', 'country': 'Zimbabwe', 'facility': 'Seke North CRS', 'geoPoint': {'lat': -18.01274, 'lon': 31.07555}}, {'city': 'Chitungwiza', 'country': 'Zimbabwe', 'facility': "St Mary's CRS", 'geoPoint': {'lat': -18.01274, 'lon': 31.07555}}, {'city': 'Harare', 'country': 'Zimbabwe', 'facility': 'Harare Family Care CRS', 'geoPoint': {'lat': -17.82772, 'lon': 31.05337}}], 'overallOfficials': [{'name': 'Mary Glenn Fowler, MD, MPH', 'role': 'STUDY_CHAIR', 'affiliation': 'Johns Hopkins Medical Institute, Makerere U.-JHU Research Collaboration'}]}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'National Institute of Allergy and Infectious Diseases (NIAID)', 'class': 'NIH'}, 'responsibleParty': {'type': 'SPONSOR'}}}}